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On 18 December 2020, the EU Drugs Strategy 2021–
2025 was approved by the Council of Europe.1 The 
strategy outlines the overarching political framework 
and priorities of the drugs policy of the European Union 
(EU) for the period.
The aim of the EU strategy is:
to protect and improve the well-being of society 
and of the individual, to protect and promote public 
health, to offer a high level of security and well-being 
for the general public and to increase health literacy. 
The strategy takes an evidence-based, integrated, 
balanced and multidisciplinary approach to the 
drugs phenomenon at national, EU and international 
level. It also incorporates a gender equality and 
health equity perspective. (p. 2)1
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In brief
Governments have always planned for the 
future, with varying degrees of success. 
However, the State’s efforts to anticipate the 
needs of future generations rarely capture the 
imagination of populations more focused on 
current economic conditions, access to public 
services, and social stability. The events of 
2020/2021 may signal a shift in the priorities of 
electorates. There has been a move towards 
climate realism in wealthier countries and a 
recognition of the need to prepare for the 
next pandemic. Making changes now to avert 
possible catastrophes decades in the future is 
no longer seen as a distraction from current 
policy concerns, but as an inevitable and core 
part of the State’s responsibilities to its present 
and future citizens.
These are global concerns and the response 
will have to be based on multilateralism and 
compromise, and the policies of individual 
nation states will largely be defined by goals set 
at an international level. Of course, individual 
states make detailed projections and decisions 
now that will have economic, social, and 
environmental impacts far into the future. But 
the idea of imagining the full range of possible 
scenarios across all policy areas, and developing 
the capacity to decide how these may impact 
resource allocation, is a relatively new one.
This is the aim of strategic forecasting. It is an 
approach to policymaking that attempts to 
manage uncertainty by identifying a number 
of possibilities. Governments, institutions, 
non-governmental organisations, and other 
national and international collective entities 
can develop anticipatory capacity by making 
better use of what is known already. Naturally, 
data are important but just as important is the 
wisdom of those who have spent many years 
learning about and working with current social 
and environmental problems. The discipline of 
strategic foresight puts particular emphasis on 
harnessing existing knowledge, not just from 
datasets but also from the minds of those most 
active, committed, and thoughtful.
The current European Commission has 
accorded strategic foresight an important 
position in the management of European Union 
(EU) policy implementation, which is evident 
in the recently published EU Drugs Strategy 
2021–2025, the topic of two articles in this issue. 
Other international institutions, such as the 
Organisation for Economic Co-operation and 
Development (OECD) and the United Nations 
Educational, Scientific and Cultural Organization 
(UNESCO), have embraced strategic foresight. 
There is, as yet, no evidence of this approach 
in Irish strategies or policy documents, but it is 
likely to become more important to policymakers 
in the next few years. Strategic foresight does 
not involve attempting to predict the future, but 
rather systematically examining current sources 
of information to imagine possible developments 
and consider what this means for current 
policymaking. Methods include horizon scanning 
to identify weak signals of change; megatrends 
analysis to explore global changes and their 
implications for local policy; and scenario 
planning and working back from an image of the 
future to decide the steps to achieve or avoid 
such an outcome.
Drug use patterns can alter rapidly in response 
to societal change or movements in popular 
culture. In the past, governments have used 
emergency measures with unpredictable 
outcomes to deal with this. Strategic forecasting, 
building on careful analysis of emerging trends 
data, may provide the opportunity to ensure 
society is better prepared when sudden change 









   











21 EU Drugs Strategy 2021–2025   
continued
This article describes the background to the  
new strategy, some of its key features, and how  
it compares with the EU’s 2013–2020 strategy.2  
It also comments on the continuing alignment 
with Ireland’s national drugs strategy.3
Background to strategy
The EU Drugs Strategy 2021–2025 sets out 
to meet its aim by providing a common and 
evidence-based framework within which to 
respond to what it terms the drugs phenomenon, 
within and outside the EU.
The strategy is underpinned by the principles 
of EU law and its founding values (respect for 
human dignity, liberty, democracy, equality, 
solidarity, the rule of law, and human rights) 
and is aligned with relevant European and 
international laws and policies. Some of the 
international legal and policy documents cited by 
the strategy as being aligned with are the United 
Nations (UN) Conventions,4 the 2016 UNGASS 
outcome document,5 relevant goals of the 2030 
Agenda for Sustainable Development,6 and the 
International Guidelines on Human Rights and 
Drug Policy7: ‘All women, men and children, 
including people with drug-use disorders, have 
the right to enjoy the highest attainable standard 
of physical and mental health, including freedom 
from violence’ (p. 3).1
Development of strategy
The strategy is the latest in a line of EU drugs 
policy documents, the first of which was 
published in 1990.8 Figure 1 presents a timeline 
of these documents. Since the EU Drugs Strategy 
2000–2004,9 there has been a policy cycle in 
which a strategy is agreed and adopted, a linked 
action plan is developed to support its delivery, 
and these are subsequently evaluated to inform 
the development of the next strategy. The first 
strategy evaluation was carried out in 200410 and 
the first external evaluation in 2012.11
Each strategy is developed through a rigorous 
process in which member states work together 
to develop the strategic approaches in a series 
of negotiations, evaluations, and compromises 
so that consensus can be reached in the form 
of a new strategy document.12 This process 
has become increasingly evidence based. The 
strategy is underpinned by various evidence 
sources (including evaluations of the previous 
strategy) as well as relevant EU and international 
law and policy documents.
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Timeline EU Strategies, Plans and Evaluations
Final evaluation
Figure 1: New timeline of EU strategies, action plans, and evaluations
Source: Based on EMCDDA (2019) p. 412
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Structure of strategy
The new strategy is a well-structured document 
and more detailed than its predecessors. It 
contains more detail on its strategic priorities 
and how it proposes to address these. Unlike 
the 2013–2020 strategy that was structured 
around two policy areas (drug demand reduction 
and drug supply reduction), the new strategy is 
structured around three:
I  Drug supply reduction: enhancing security
II  Drug demand reduction: prevention,  
treatment, and care services
III  Addressing drug-related harm
These are supported by three cross-cutting 
themes that reflect those in the earlier strategy:
IV International cooperation
V Research, innovation, and foresight
VI Coordination, governance, and 
implementation.
Eleven strategic priorities underpin these policy 
areas and themes, with a list of priority areas 
to address. See the accompanying article, ‘EU 
Drugs Strategy 2021–2025: policy areas, themes, 
and strategic priorities’, on page 7, for a full list.
Focus of new strategy
While a more comprehensive document than 
its predecessors, the new strategy signals a 
continuation in the overall direction for the 
EU in its approach through a balance of supply 
and demand reduction activities. However, 
there appears to be an increased focus on 
the consequences of drug use and its related 
harms, which is apparent in a new policy area 
on ‘addressing drug-related harm’. It focuses on 
measures and policies aimed at preventing or 
reducing the health and social risks and harms 
for people who use drugs, for society, and for 
those in prison settings.
EU Drugs Strategy 2021–2025   
continued
Most of the priority areas contained in the 
strategy (including in the new policy area 
‘addressing drug-related harm’) are not new to 
EU drug policy. However, they are presented 
in more detail which illustrates with greater 
clarity both the EU’s position and how the 
drug landscape has evolved since the previous 
strategy was published in 2012. For example, 
drug markets have changed significantly. Dealing 
with the use of social media platforms, apps, and 
internet/darknet marketplaces for the sale of 
illicit drugs and the associated payment systems 
has become a priority area for the EU. There 
has been an increase in drug-related violence 
which is also reflected in the new strategy. For 
example, the need to recognise the impact of 
drug-related crime, particularly on communities, 
and to counter the exploitation of children by 
organised crime groups is acknowledged. An 
example of a completely new issue to feature in 
the strategy is environmental crime related to 
illicit drug production and trafficking. This relates 
to the environmental impacts, hazards to health, 
and costs associated with the chemical waste 
generated by illicit synthetic drug production, 
as well as the handling and destruction of seized 
substances.
Alignment with Irish drugs strategy
While the Department of Health did not set 
out to mirror the EU’s 2013–2020 strategy 
when developing Ireland’s national drugs 
strategy (2017–2025), there was significant 
overlap between the two. There continues to 
be close alignment with the new EU strategy, 
in the overarching goals and policy areas 
and in the objectives and strategic priorities. 
Ireland’s drugs strategy reflects a similarly 
balanced approach to addressing both supply 
and demand reduction activities, although 
there is more emphasis in the Irish strategy 
on taking a health-led rather than a criminal-
justice-led approach. Very similar priorities are 
identified across the board, including in the 
areas of prevention, treatment, harm reduction, 
rehabilitation/recovery/reintegration, drug 
markets, legislation, law enforcement, and drug 
monitoring. Given the move by the EU towards a 
strategy with an increased focus on health and 









   












closely aligned. When welcoming the new EU 
strategy, Frank Feighan TD, Minister of State for 
Public Health, Wellbeing and the National Drugs 
Strategy, said that Ireland had advocated for this 
increased focus on health:13
I welcome the new focus on the health needs 
of people who use drugs in the EU strategy, 
which mirrors the health-led approach in 
our national strategy, Reducing Harming, 
Supporting Recovery. Ireland strongly 
advocated for the inclusion of harm reduction 
in the strategy, along with traditional policies 
to reduce the supply and the demand for 
drugs.13
Both strategies emphasise the importance 
of research and adopting an evidence-
based approach to implementation. A strong 
commitment to upholding human rights 
underpins the EU’s position and is also apparent 
in the Irish strategy. However, the language in 
the Irish strategy is framed around the health-
led approach rather than using the language of 
human rights as such.
The Irish strategy explicitly aligns itself with the 
EU and other international partners on a range 
of activities: for example, on intercepting drugs – 
and precursors for diversion to the manufacture 
of drugs – being trafficked to Ireland, and on 
early warning and emerging trends networks. As 
part of an action to strengthen Ireland’s drug 
monitoring system, the Irish strategy commits to 
using European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA) protocols to monitor 
the drug situation and to be able to respond to 
new data monitoring requests from the EU. This 
national approach fits well with that outlined in 
the EU strategy.
Moving forward, this alignment is set to continue. 
Both the EU and Ireland are due to agree new 
action plans for the period from 2021 to deliver 
on their strategies. Minister Feighan has stated 
that there will be synergy between the two 
action plans:
The EU Drugs Strategy and the forthcoming 
action plan are very timely as it will inform 
the mid-term review of actions in the national 
drugs strategy. Ireland cannot address the 
drugs issue in isolation from our European 
colleagues. I want to ensure that there is 
a synergy between the EU and national 
strategies and to avail of the opportunities 
provided in the EU strategy to share learning 
and good practice between member states.13
Concluding comment
The new EU drugs strategy is a more 
comprehensive document than its predecessors. 
It signals an ongoing commitment to a balance 
of supply and demand reduction activities 
to address the drugs phenomenon, although 
an increased emphasis on addressing the 
consequences and harms of drug use is 
apparent. There is synergy in the approaches 
of Ireland and the EU, which would suggest 
having opportunities to collaborate and draw 
on the evidence base and experience of other 
European member states. The EU Action Plan 
on Drugs (2021–2025) currently being drawn up, 
and which is set to be adopted during Portugal’s 
presidency of the EU later in 2021, will inform 
Ireland’s action plan for the remainder of the 
national strategy’s lifetime.
Lucy Dillon
1 Council of the European Union (2020) EU drugs 
strategy 2021–2025. Brussels: Council of the 
European Union.  
https://www.drugsandalcohol.ie/33750/
2 Council of the European Union (2012) EU drugs 
strategy (2013–2020). Brussels: Council of the 
European Union.  
https://www.drugsandalcohol.ie/19034/
3 Department of Health (2017) Reducing harm, 
supporting recovery: a health-led response to 
drug and alcohol use in Ireland 2017–2025. Dublin: 
Department of Health.  
https://www.drugsandalcohol.ie/27603/
4 These include the 1961 UN Single Convention 
on Narcotic Drugs, as amended by the 1972 
Protocol; the 1971 UN Convention on Psychotropic 
Substances; and the 1988 UN Convention against 
Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances.
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York: United Nations.  
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7 United Nations Development Programme (2019) 
International guidelines on human rights and drug 
policy. New York: United Nations Development 
Programme.  
https://www.drugsandalcohol.ie/30447/
8 European Committee to Combat Drugs (CELAD) 
(1990) European plan to combat drugs. Brussels: 
European Council.  
https://www.drugsandalcohol.ie/33749/
9 Council of the European Union (1999) European 
Union drugs strategy (2000–2004). Brussels:  
Council of the European Union. 
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EU Drugs Strategy 2021–2025   
continued
10 Commission of the European Communities (2004) 
Communication from the Commission to the 
Council and the European Parliament on the results 
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final. Brussels: Commission of the European 
Communities.  
https://www.drugsandalcohol.ie/33757/
11 Culley DM, Skoupy J, Rubin J, Hoorens S, Disley 
E and Rabinovich L (2012) Assessment of the 
implementation of the EU Drugs Strategy 2005–
2012 and its Action Plans. Santa Monica, CA: Rand 
Europe/European Commission Directorate General 
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https://www.drugsandalcohol.ie/17312/
12  European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) (2019) The EU drugs strategy: 
a model for common action. Lisbon: EMCDDA. 
https://www.drugsandalcohol.ie/31190/
13 Department of Health (2021) Minister Feighan 
welcomes the approval of the EU Drugs Strategy 
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EU Drugs Strategy 
2021–2025: policy 
areas, themes, and 
strategic priorities
This article outlines the policy areas, cross-
cutting themes, and strategic priorities of the 
EU Drugs Strategy 2021–2025, as they appear in 
the published document.1 The policy areas and 
themes are listed in Table 1.
No. Policy area
I Drug supply reduction: enhancing 
security
II Drug demand reduction: prevention, 
treatment, and care services
III Addressing drug-related harm
IV International cooperation
V Research, innovation, and foresight
VI Coordination, governance, and 
implementation
Table 1: Policy areas and cross-cutting 









   











21 EU Drugs Strategy 2021–2025   
continued
Policy area I: Drug supply reduction  
– enhancing security
An objective of the strategy is to respond, 
through an evidence-based approach, to the 
challenging development of European Union 
(EU) drug markets, which are characterised by 
high availability of various types of drugs, ever 
larger seizures, increasing use of violence, and 
huge profits. The strategy aims to contribute 
to the disruption of traditional and online illicit 
drug markets; the dismantling of organised 
crime groups involved in drug production 
and trafficking; efficient use of the criminal 
justice system; effective intelligence-led law 
enforcement; a reduction in the levels of 
violence associated with the illicit drug markets; 
and increased intelligence sharing to ensure a 
common approach on the part of all responsible 
stakeholders.
Strategic priority 1
Disrupt and dismantle high-risk drug-related 
organised crime groups operating in, originating 
in or targeting the EU member states; address 
links with other security threats and improve 
crime prevention.
Priority areas to address:
1.1 Target high-risk organised crime groups 
active across the EU and cross-border drug 
markets; set priorities in synergy with the 
EU policy cycle for organised and serious 
international crime (EMPACT)2; disrupt 
criminal business models, especially those 
that foster collaboration between different 
organised crime groups; and address links 
with other security threats.
1.2 Track, trace, freeze and confiscate the 
proceeds of and instruments used by 
organised crime groups involved in the illicit 
drug markets.
1.3 Prevent drug-related crime with particular 
focus on the need to counter violence, limit 
corruption, and address the exploitation 
of vulnerable groups by addressing the 
underlying factors that lead to their 
involvement in illicit drug markets.
Strategic priority 2
Increase the detection of illicit wholesale 
trafficking of drugs and drug precursors at EU 
points of entry and exit.
Priority areas to address:
2.1 Counter the smuggling of drugs and drug 
precursors in and out of the EU by using 
established legitimate trade channels.
2.2 Increase monitoring of border crossings 
that are not part of established trade 
channels to more effectively prevent illicit 
or undeclared crossings of the EU external 
borders.
Strategic priority 3
Tackle the exploitation of logistical and digital 
channels for medium- and small-volume illicit 
drug distribution and increase seizures of illicit 
substances smuggled through these channels in 
close cooperation with the private sector.
Priority areas to address:
3.1 Tackle digitally enabled illicit drug markets.
3.2 Target drugs trafficking via postal and 
express services.
3.3 Reinforce monitoring and investigation 
methods for cross-EU rail and fluvial 
channels and the general aviation space.
Strategic priority 4
Dismantle illicit drug production and counter 
illicit cultivation; prevent the diversion and 
trafficking of drug precursors for illicit drug 
production; and address environmental damage.
Priority areas to address:
4.1 Counter illicit production of synthetic drugs 
and illicit cultivation of drugs.
4.2 Tackle the diversion and trafficking of 
drug precursors and the development of 
alternative chemicals.3
4.3 Address environmental crime related to 
illicit drug production and trafficking.
9
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Policy area II: Drug demand reduction  
– prevention, treatment, and care 
services
In the area of drug demand reduction, the 
objective of the strategy is to contribute to the 
healthy and safe development of children and 
young people and to a reduction in the use of 
illicit drugs. It aims to delay the age of onset, 
to prevent and reduce problem drug use, to 
treat drug dependence, to provide for recovery 
and social reintegration through an integrated, 
multidisciplinary, and evidence-based approach 
and by promoting and safeguarding coherence 
between health, social, and justice policies.
Strategic priority 5
Prevent drug use and raise awareness of the 
adverse effects of drugs.
Priority areas to address:
5.1 Provide, implement, and, where needed, 
increase the availability of evidence-based 
environmental and universal prevention 
interventions and strategies for target 
groups and environments, in order to 
increase resilience and strengthen life skills 
and healthy life choices.
5.2 Provide, implement, and, where needed, 
increase the availability of evidence-based 
targeted prevention interventions for young 
people and other vulnerable groups.
5.3 Provide, implement, and, where needed, 
increase the availability of evidence-based 
early intervention measures.
5.4 Disseminate the latest scientific evidence 
on prevention to decision-makers and 
practitioners and provide them with training.
5.5 Address drug-impaired driving.
Strategic priority 6
Ensure access to and strengthen treatment and 
care services.
Priority areas to address:
6.1 Ensure voluntary access to treatment 
and care services that work in close 
coordination and collaboration with other 
health and social support services.
6.2 Promote peer work.
6.3 Identify and remedy the barriers to 
accessing treatment and ensure and, where 
needed, extend coverage of treatment and 
care services based on individual needs.
6.4 Reduce stigma.
6.5 Widely implement treatment and care 
addressing the specific needs of women.
6.6 Implement models of care that are 
appropriate for groups with special care 
needs.
6.7 Provide and, where needed, improve 
access to availability and appropriate use 
of substances for medical and scientific 
purposes.
Policy area III: Addressing drug-related 
harm
The use of drugs may cause health and social 
harm to users but also to their family and the 
wider community. This policy area focuses on 
measures and policies that prevent or reduce 
the possible health and social risks and harm for 
users, for society, and in prison settings.
Strategic priority 7
Risk-reduction and harm-reduction 
interventions and other measures to protect and 
support people who use drugs.
Priority areas to address:
7.1 Reduce the prevalence and incidence of 
drug-related infectious diseases and other 
negative health and social outcomes.
7.2 Prevent overdoses and drug-related deaths.
7.3 Promote civil society participation and 
ensure sustainable funding.
7.4 Provide alternatives to coercive sanctions.










   













Address the health and social needs of people 
who use drugs in prison settings and after 
release.
Priority areas to address:
8.1 Assure equivalence and continuity of 
healthcare provision in prison and by 
probationary services.
8.2 Implement evidence-based measures in 
prison settings to prevent and reduce drug 
use and its health consequences, including 
measures to address the risk of drug-related 
deaths and the transmission of blood-borne 
viruses.
8.3 Provide overdose prevention and referral 
services to ensure continuity of care on 
release.
8.4 Restrict the availability of drugs in prisons.
Cross-cutting theme IV: International 
cooperation
Strategic priority 9
Strengthening international cooperation with 
third countries, regions, international, and 
regional organisations, and at multilateral level 
to pursue the approach and objectives of the 
strategy, including in the field of development. 
Enhancing the role of the EU as a global broker 
for a people-centred and human rights-oriented 
drug policy.
Priority areas to address:
9.1 Continue shaping the international and 
multilateral agendas on drug policy.
9.2 Ensure a sustainable level of dialogue and 
information sharing on the strategies, aims, 
and relevant initiatives with third countries 
or regions.
9.3 Foster international cooperation by further 
involving competent EU agencies within 
their respective mandates.
9.4 Continue and establish new cooperation 
programmes with third countries or regions 
and other partners based on regular 
evaluations of such programmes.
9.5 Address all the policy aspects of the strategy 
in international cooperation, including in the 
fields of security and judicial cooperation as 
well as the health-related aspects of drugs 
issues.
9.6 Strengthen the commitment to 
development-oriented drug policies and 
alternative development measures.
9.7 Protect and promote adherence to 
international human right standards and 
obligations in global drug policies.
Cross-cutting theme V: Research, 
innovation, and foresight
Strategic priority 10
Building synergies to provide the EU and 
its member states with the comprehensive 
research evidence base and foresight capacities 
necessary to enable a more effective, innovative, 
and agile approach to the growing complexity 
of the drugs phenomenon, and to increase the 
preparedness of the EU and its member states to 
respond to future challenges and crises.
Priority areas to address:
10.1 Strengthen and broaden research capacities 
and encourage the greater sharing and use 
of results.
10.2 Foster innovation so that policy and actions 
shift from a reactive to a proactive mode.
10.3 Develop strategic foresight and a future-
oriented approach.
10.4 Strengthen coordination and synergies, and 
support the central role of the European 
Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA), Europol, and the 
Reitox network of national focal points in 
research, innovation, and foresight.
10.5 Ensure adequate financing for drug-related 
research, innovation, and foresight.
EU Drugs Strategy 2021–2025   
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Cross cutting theme VI: Coordination, 
governance, and implementation
Strategic priority 11
Ensuring optimal implementation of the strategy 
and of the action plan, coordination by default of 
all stakeholders, and the provision of adequate 
resources at EU and national levels.
While this strategic priority does not have a 
list of specific priority areas to address, it is 
underpinned by 10 points for delivery.
Ten points for delivery
11.1 An action plan will be developed to guide 
delivery of the strategy.
11.2 Implementation should facilitate synergies 
and consistencies between EU and national 
level policies.
11.3 The strategy and action plan will be subject 
to external evaluation.
11.4 Appropriate and targeted resources should 
be allocated for the implementation of the 
objectives of this strategy at both EU and 
national level.
11.5 The European Commission will present 
a proposal to revise the mandate of the 
EMCDDA to ensure that the agency plays a 
stronger part in addressing the current and 
future challenges of the drug phenomenon. 
The EMCDDA and Europol should be 
provided with the relevant resources to 
enable them to fulfil their roles.
11.6 There should be coordination with agencies, 
bodies or organisations that have relevance 
for the drugs field, within their respective 
mandates both within and outside the EU.
11.7 The Horizontal Working Party on Drugs 
(HDG), as the main coordinating body 
on drug policy in the Council of the EU, 
should be kept informed of possible work 
linked to drugs issues, carried out by other 
preparatory bodies of the council.
11.8 Coordination and synergies should be 
sought between the drug policy and the 
other policies, including in the security and 
health areas.
11.9 Externally, the EU and its member states 
should promote the approach and 
objectives of the strategy with one voice.
11.10 The meaningful participation and 
involvement of civil society should 
be ensured in the development and 
implementation of drug policies, at national, 
EU, and international levels.
Compiled by Lucy Dillon
1 Council of the European Union (2020) EU drugs 
strategy 2021–2025. Brussels: Council of the 
European Union.  
https://www.drugsandalcohol.ie/33750/
2 Europol (2020) EU policy cycle – EMPACT. The 
Hague: Europol. Available online at:  
https://www.europol.europa.eu/empact
3 The term 'alternative chemicals' covers the wide 
range of substances variously referred to in 
both official and unofficial reports as ‘designer 
precursor’, ‘masked precursor’, ‘pre-precursor’, or 
‘masked drug’. See page 2 of European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) 
(2019) Drug precursor developments in the 
European Union. Luxembourg: Publications Office 
of the European Union.  
https://www.drugsandalcohol.ie/31363/










   











21 Evaluation of EU 
Drugs Strategy  
2013–2020
The new European Union (EU) Drugs Strategy 
2021–20251 was published in December 2020 
and is discussed in other articles in this issue 
of Drugnet. It is informed by the findings of the 
evaluation of the EU Drugs Strategy 2013–2020 
and the EU Action Plan on Drugs 2017–2020, 
which was published in July 2020.2,3
The evaluation was one of a suite of documents 
launched as part of the European Commission’s 
EU Security Union Strategy 2020–2025,4 which 
considered drugs within the broader context of 
fostering security for all those living in Europe:
From combatting terrorism and organised 
crime, to preventing and detecting hybrid 
threats and increasing the resilience of 
our critical infrastructure, to promoting 
cybersecurity and fostering research and 
innovation, the strategy lays out the tools and 
measures to be developed over the next 5 
years to ensure security in our physical and 
digital environment.4
Scope of the evaluation
The EU Drugs Strategy 2013–20205 was based 
on a five-pillar structure that consisted of two 
main policy areas – the reduction of both drug 
demand and supply – and three cross-cutting 
themes: coordination; international cooperation; 
and research, information, monitoring, and 
evaluation. The EU Action Plan on Drugs 2017–
20206 followed on from the EU Action Plan on 
Drugs 2013–20167 and set out to facilitate the 
implementation of the priorities laid out in the 
strategy. As with its predecessor, the 2017–2020 
action plan was structured around the objectives 
aligned to the five pillars, which were further 
divided into a set of concrete actions allocated 
to relevant stakeholders with a timeline for 
implementation. Indicators and data collection 
mechanisms were identified to support 
monitoring and evaluation.
The evaluation aimed to assess the 
implementation of the strategy and the 2017–
2020 action plan in terms of outputs, results, and 
impacts. These were considered in the context 
of the five mandatory evaluation criteria set out 
in the European Commission’s Better Regulation 
Guidelines8: relevance, coherence, effectiveness, 
efficiency, and EU-added value. A mixed-
method approach was taken in the evaluation, 
which involved accessing a wide range of data 
sources and consultation with stakeholders. 
Those consulted through the process included 
EU member states, competent authorities, civil 
society organisations, and the general public.
In its simplest terms, the analytical framework of 
the evaluation compares the baseline situation 
in the EU in 2013 (for each of the five pillars and 
objectives) with how things stood in 2020 (the 
implementation state of play). It then examines 
the extent to which the actions and outputs 
that can be observed through relevant evidence 
sources (including feedback from stakeholders) 
correspond to what was expected to have been 
achieved by the strategy through its action 
plans. For a more detailed description of the 
methodological approach and its limitations, 
readers should access the full evaluation report.3
Findings of the evaluation
The key findings, as laid out in the evaluation 
report and its executive summary, were:
• The technological, social, political, and 
environmental context affecting the demand 
and supply of drugs was found to have evolved 
considerably since 2013, making the strategy 
and action plan only partially relevant to the 
drug situation at the time of the evaluation.
• The strategy and action plan were found 
to have remained largely consistent with 
relevant European legislation and policy at 
international level. However, changes in the 
drug situation since 2013 were considered 
to have weakened the coherence between 
the strategy and the broader policy fields of 
health and security.
• The strategy and action plan were found to 
have been only partially effective in achieving 
13
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the drug demand reduction objective. 
Progress had been made in some areas: 
for example, there were increases in the 
variety of general and specific prevention 
and treatment interventions that had been 
implemented across many EU member states. 
However, there had not been a reduction in 
drug demand across the EU in comparison 
with 2013. In fact, prevalence of drug use 
‘increased across most types of drugs across 
most member states since the baseline 
year. The overall increase was particularly 
pronounced amongst young people. Finally, 
drug-related deaths across the EU have also 
increased’ (p. 21).3
• Similarly, the strategy and action plan were 
only partially effective in achieving the drug 
supply reduction objective. The evaluation 
found progress had been made in terms of 
effective law enforcement coordination and 
cooperation within the EU. However, it also 
found that the estimated availability of most 
types of drugs had increased in the EU since 
2013. Drug purity had also largely increased 
over the same period. It also notes that the 
large-scale operations conducted seemed to 
have been largely insufficient to disrupt the 
illicit drug markets.
• Where the strategy and action plan had 
been most effective was in delivering 
on the three cross-cutting objectives 
(coordination; international cooperation; 
and research, information, monitoring, and 
evaluation). Overall, drug policy was found 
to be effectively coordinated at EU and 
international levels; the EU spoke with ‘one 
voice’ on drug policy on the international 
stage.
• In light of the findings, the evaluators 
conclude that ‘generally speaking, it would 
seem that the strategy did not make 
significant contributions towards achieving its 
planned overall impact to ensure a high level 
of human health protection, social stability 
and security’ (p. 38).3
• In terms of efficiency, there was no conclusive 
evidence on whether the results attributed 
to the strategy and action plan were achieved 
at a reasonable or unreasonable cost. The 
evaluators could not carry out a sound 
assessment on efficiency as quantifiable data 
regarding drugs-policy-related costs were not 
widely available from member states.
• One of the successes of the strategy and 
action plan was that they generated EU-
added value insofar as they achieved results 
that national or other European initiatives 
would not have achieved. This included 
establishing ‘a common strategic framework’ 
and ‘bridging’ between member states 
and different levels of governance. They 
‘encouraged cross-border coordination and 
exchange of information and evidence-based 
best practices among member states and 
thus created economies of scale in terms of 
synergies and efficiencies’ (p. 39).3
• The stakeholder consultations found 
continued support from member states and 
civil society organisations for strategic EU 
involvement in drugs policy; it was argued 
that to discontinue an EU-wide drugs strategy 
would likely have negative effects.
Recommendations of the evaluation
In terms of feeding into the next strategy (2021–
2025), the evaluation made recommendations 
related to its structure and focus. It was 
recommended that it be more concrete in its 
actions and priorities and that the monitoring 
system should be simplified. It was also 
recommended that it should cover a shorter 
period of time. Taking account of changes in the 
drugs landscape, it recommended that future 
priorities need to consider trends such as:
…increased poly-criminality of organized 
crime groups and their adaptive and 
innovative modus operandi; role of the EU as 
a producer and exporter; increased levels 
of violence and corruption that enable the 
drug trade; technologic enablers such as 
darknet marketplaces, cryptocurrencies 
and encryption technology for buying/selling 
drugs; new patterns of drug consumption 
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between young people and the aging 
population, as well as gender differences; 
societal and environmental effects. The 
consequences of the drug phenomenon are 
becoming more complex and intertwined, 
extend across different sectors and go beyond 
EU’s borders. The future strategic approach 
to EU drugs policy must be evidence-based, 
balanced and further integrated to reflect the 
relevant trends that the EU will be facing in 
the coming years. (p. 2)2
Conclusion
The findings of the evaluation reflect the 
complexities of the drugs landscape and the 
policies and interventions required to address 
the issues it presents. While the evaluation 
illustrates the effectiveness of an EU-wide 
strategy in supporting cross-cutting objectives, 
it struggles to show the impact on elements 
of the drug demand and supply pillars, which 
are central to the strategy. The new EU drugs 
strategy is discussed in other articles in this issue 
of Drugnet. It is clear that the recommendations 
of this evaluation that relate to structure 
and focus were taken into account in its 
development. However, challenges identified in 
this evaluation will remain. For example, how to 
adapt to an ever-evolving landscape and how to 
capture the necessary evidence to understand 
whether the approach adopted in the strategy is 
the most effective in addressing the needs. More 
importantly, how better to achieve drug demand 
and supply reductions.
Evaluation of EU Drugs Strategy 
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Most recent 
regulations of Public 
Health (Alcohol) Act 
2018 implemented
October 2018 saw the much-anticipated 
enactment of the Public Health (Alcohol) 
Act1 and heralded a recognition by the 
Irish Government that our nation’s harmful 
relationship with alcohol could no longer be 
ignored. The legislation seeks to limit the damage 
to the nation’s health, society, and economy 
by reducing alcohol consumption; delaying the 
initiation of alcohol consumption by children and 
young people; reducing the harms caused by the 
misuse of alcohol; and ensuring the supply and 
price of alcohol is regulated and controlled in 
order to minimise the possibility and incidence 
of alcohol-related harm.
The most recent measures from the Act 
that commenced are Section 22 (structural 
separation) and Section 23 (restrictions on the 
sale and supply of alcohol products).
Section 22 – structural separation of 
alcohol from grocery products
Limiting the physical availability of alcohol 
is an important measure to reduce alcohol 
consumption and consequently alcohol-related 
harm. The Act recognises that alcohol is ‘no 
ordinary product’.2 This is particularly pertinent 
to Section 22 of the Act, which requires that 
alcohol products are kept separate from other 
grocery products in mixed retail outlets such 
as supermarkets, grocery stores, convenience 
stores, and petrol stations. It also requires 
that alcohol products and advertisements for 
alcohol products are not visible outside of these 
designated areas.
Section 22 is intended to ensure that access to 
alcohol products and the advertising of same is 
more controlled and less likely to be on display 
near grocery products, thereby discouraging 
their purchase as part of everyday household 
grocery shopping, and less visible to children. 
Section 22 was commenced on 12 November 
2018 and retailers had a two-year lead-in period 
until 12 November 2020 when they were legally 
obliged to store alcohol products in one of 
following options (see Figure 1).3
• Option A: A single area reserved for alcohol 
and alcohol-related products separated by a 
barrier.
• Option B: Enclosed storage unit(s) adjacent 
to each other containing alcohol products 
and advertisements for alcohol products with 
height and visibility restrictions.
• Option C1: Display of alcohol products and 
advertisements for alcohol products within a 
maximum of three adjacent storage units with 
height and width restrictions on each unit.
• Option C2: Closed storage unit behind the 
counter.
The new regulations, monitored by Health 
Service Executive (HSE) environmental health 
officers, do not apply to standalone off-licences, 
airports, or passenger aircraft.
Section 23 – restrictions on the sale  
and supply of alcohol products
Section 23 of the Act refers to the ‘sale and 
supply of alcohol products’ and four of its 
regulations came into effect on 11 January 2021. 
Section 23 regulations4 are intended to prohibit 
promotions encouraging risky drinking, that is, 
that encourage individuals to purchase or drink 
more than they intended or to drink faster than 
they intended.
1 Regulation 3 applies to the award of or use 
of bonus or loyalty card points in relation to 
the sale of alcohol products. Bonus or loyalty 
card points cannot be awarded from the sale 
of alcohol or cannot be used to purchase 
alcohol. This includes loyalty card points 
awarded on the use of a fuel service station, 
credit card, energy service provider, phone 
service provider, holiday breaks, or insurance. 
Loyalty card points converted to vouchers 
may not be used to purchase alcohol, 
including in a restaurant, theatre, cinema, or 









   












2 Regulation 4 applies to the sale and 
advertisement of alcohol products at a 
reduced price or free of charge when sold 
with one or more alcohol products, or 
another product or service: for example, ‘buy 
one get one free’ or ‘buy one, get one half 
price’. The same applies in licensed premises, 
that is, two drinks bought together for less 
than the price of two individual drinks. A free 
glass of wine offered at, for example, a nail 
bar, hairdressers or barbers is not permitted. 
The purchase of a service such as a manicure 
or haircut may not result in the offer of an 
alcohol product free of charge.
3 Regulation 5 applies to the sale and 
advertisement of alcohol products at a 
reduced price for a period of three days or 
less: for example, ‘Student Night’ or ‘Happy 
Hour’.
4 Regulation 6 covers the prohibition of 
advertising any of the ‘discount’ promotions 
outlined above in Regulations 4 and 5.
The regulations apply to the online sale and 
supply of alcohol products on Irish websites but 
not to the sale of alcohol by wholesale. A person 
who contravenes these prohibitions commits an 
offence and is subject to penalties ranging from a 
Class A fine or up to three years’ imprisonment.
Conclusion
The implementation of these regulations 
are welcomed and timely given that we are 
reportedly drinking more than usual during the 
Covid-19 pandemic and are buying alcohol from 
mixed retail outlets due to the closure of pubs.5,6 
It is crucial that the remaining elements of the 
Act are implemented given the current high rates 
of alcohol consumption, binge drinking, and 
alcohol dependence in Ireland.
Anne Doyle
1 Government of Ireland (2018) Public Health (Alcohol) 
Act 2018. Available online at:  
http://www.irishstatutebook.ie/eli/2018/act/24/
enacted/en/html
Option A: In an area of the shop that is separated by 
a physical barrier with height restrictions. Shoppers 
should not have to pass through the separated area to 
gain access to another area of the shop or to make a 
purchase of products other than alcohol.
Option B: In a maximum of three adjacent units. The 
units must not contain products other than alcohol 
products and advertisements for alcohol products.
Option C1: In one or more closed adjacent storage 
units or cabinets on the shop floor with height and 
visibility restrictions (so alcohol products cannot be 
seen when the unit is closed). The unit should remain 
closed when not in use.
Option C2: In a closed storage unit behind the 
counter. The unit may indicate that it contains alcohol 
products but shall not be accessible to members of 
the public and should remain closed when not in use.
Figure 1: Options for storing alcohol 
products under new regulations
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of public health 
advocates in Ireland
Policy researchers have long been interested 
in the processes that facilitate major policy 
change.1 A 2021 study2 explores the role of the 
public health advocacy coalition in promoting 
the passage of the Public Health (Alcohol) Bill 
in Ireland. Following a five-year campaign, the 
Public Health (Alcohol) Bill was approved by 
the Government in December 2015 and after a 
protracted and contested process the legislation 
was signed into law on October 2018.
The alcohol industry and the public health 
community formed two opposing coalitions 
during the policy debate.3 The alcohol 
industry’s success in resisting population-
level approaches to alcohol policy has been 
identified in Ireland4,5,6,7–11 and elsewhere.12–20 In 
contrast, public health advocates have typically 
had limited success. Yet in this case, public 
health advocates in Ireland have developed 
sophisticated political strategies to foster major 
alcohol policy change.
Methodology
The study constructed a record of the public 
health advocacy coalition and its campaign to 
promote the Public Health (Alcohol) Act 2018 
in Ireland. To identify the key actors and issue 
frames, a thematic analysis was undertaken using 
primary documents produced by advocates, 
newspaper articles, and semi-structured 
interviews with key advocates, public health 
experts, and elected officials.
This analysis documented the growing political 
sophistication and effectiveness of public health 
advocates in Ireland. First, a broad-based 
coalition enabled advocates to pool resources 
and coordinate their strategy and messaging. 
Second, issue-framing was critical in shifting 
the focus of the debate to alcohol-related 
harm. This placed pressure on politicians by 
making available evidence on the extent of the 
problem. Finally, evidence of political learning 
was presented, where advocates’ knowledge 
of the political system spurred innovations in 
campaigning.










   












These three strategies – coalition-building,21 
issue-framing,22 and political learning23,3 – are 
discussed in more detail below.
Coalition-building
The public health alcohol advocacy community 
in Ireland had traditionally comprised a relatively 
small group of non-governmental organisations 
(NGOs), public health experts, and public 
health officials. However, a concerted push to 
professionalise advocacy since the 2000s saw 
Alcohol Action Ireland (AAI), a national advocacy 
organisation, participating in numerous policy 
deliberations including the National Substance 
Misuse Strategy (NSMS) Steering Group. When 
the Government announced it would be acting 
on the policy recommendations of the NSMS 
report, AAI mobilised a cross-party group of 
senators and TDs.
Interest in alcohol policy also extended to the 
Irish medical establishment, leading to the 
formation of an alcohol policy group in 2012. 
Key figures in the Royal College of Physicians of 
Ireland (RCPI) and AAI decided to mobilise other 
organisations who supported the key principles 
of the Bill. This Alcohol Health Alliance Ireland 
brought together 62 organisations.
The establishment of this broad coalition 
allowed members to effectively pool their 
limited resources. Drawing ‘on the strength and 
the reputations’ of its membership helped to 
strengthen the advocates’ credibility giving them 
‘more clout with the public, with politicians, and 
with the media’.2 As one advocate explained, 
AAI had been ‘a small charity, a small voice, 
[and] a lone voice, with a limited budget’, and 
so the inclusion of organised medicine enabled 
the alliance to ‘speak with more authority’ on 
alcohol harms.
The coalition coordinated its strategy and 
maintained message discipline by advising 
experts ahead of their media appearances. 
As one member remarked, traditionally there 
were ‘lots of disparate voices shouting out in an 
uncoordinated way’.2 The alliance ensured that 
when an issue was raised in the media, the most 
effective voice articulated the public health 
position.
The alliance also recruited individuals from 
member organisations who possessed a 
background in public affairs, including those 
with prior roles as journalists and as political 
advisers, thus possessing an intimate knowledge 
of the political system. The close working 
relationships with politicians and key officials 
within the Department of Health allowed the 
alliance to keep ‘on top of what was happening in 
government … and what … might have been said 
in the media’.2
Issue-framing
A key framing strategy was to focus on the 
content of the problem – the health harms – 
rather than the particular measures within the 
Bill itself. Advocates made extensive use of social 
media and developed multimedia strategies to 
establish their preferred framing. The alliance 
used its website and other communication 
materials, including infographics, to highlight 
the harms caused by high levels of alcohol 
consumption. Advocates released hundreds of 
documents, including reports and press releases, 
to generate media coverage. Advocates also used 
social media, press interviews, and editorials at 
key stages of the Bill’s progression to underline 
the principal harms frame.24–27
Although it faced entrenched alcohol industry 
positioning, it found ways to pivot when 
confronting less advantageous frames. For 
example, when industry identified the economic 
costs of the Bill, advocates responded by 
highlighting the healthcare costs associated 
with the status quo. According to one citation, 
the alliance’s ‘expert stakeholder alliances and 
evidence-based communications’2,28 succeeded 
in keeping alcohol on the agenda for more than 
three years, despite facing a ‘well-resourced and 
culturally-embedded opposition’.28
Political learning
There is evidence of political learning23 where 
advocates’ prior experiences and knowledge 
of the political system in Ireland spurred 
innovations in campaigning. Key lessons had 
Public health advocates in Ireland 
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been drawn from other successful public health 
campaigns including the smoking ban.
The specific expertise of the advocates was 
critical to the Bill’s passage, including experience 
in politics, journalism, and in campaigning 
organisations. Politicians were targeted and 
close relationships were formed with those 
who were sympathetic, broadening the 
coalition, and leveraging these interactions to 
shape the legislative process. Local grassroots 
organisations also played a key role in reinforcing 
this tactic at a local level. These strategies were 
interdependent and mutually reinforcing, and 
succeeded in building support for public health 
advocates’ preferred policies among politicians 
and the general public.
Advocates exhibited sophistication throughout 
the debates over the Bill. One expert, who was 
not formally involved in the coalition, had this to 
say about its influence:
[The alliance] was pivotal because they made 
it a campaign and they ran it like a campaign 
….Campaigns are not accidental things … 
they have to have many arms … they have to 
have a communications arm, a political arm, 
a policy arm, [and] a civil service arm … I think 
they covered all the bases … I think the public 
health side [was] strong and … more savvy 
than before.2
Discussion
These findings provide insights into the 
developing capacity of advocates to drive major 
policy change. The success of the alcohol 
advocacy coalition in its campaign to pass 
the Public Health (Alcohol) Bill was a hard-
fought campaign but other equally hard-fought 
advocacy campaigns preceded it, including 
the ban on smoking in public places as well as 
national referenda on divorce, abortion, and 
same-sex marriage. Such successes generate 
momentum and are relevant to appreciating 
how the broader advocacy community has 
professionalised over time.
Ireland’s long-standing problematic relationship 
with alcohol as well its failure to get to grips 
with the problem is another important 
consideration.4–6,8 Several Irish experts have 
been instrumental in generating high-level 
awareness of the existence of a problem, 
gradually reframing the problem away from an 
issue affecting a subgroup of ‘alcoholics’ towards 
a fuller population-level understanding of alcohol 
harms. Politicians were receptive to major policy 
change due in part to sustained public attention 
to alcohol as a problem.8
This study contributes to a broader research 
programme on the alcohol industry and the 
role of evidence in alcohol policymaking.18,29–31 
A recurring finding on the alcohol industry is 
the advantages it holds over its opponents with 
respect to resources and lobbying efforts.28 This 
study, however, shows that experts often possess 
unique capabilities or attributes – such as public 
trust – which can help to mitigate the industry’s 
resource advantage.
Finally, the prolonged development of alcohol 
policy innovation in Ireland underscores the 
perennial role of conflict. The Irish advocacy 
coalition saw itself as fighting a war with industry 
in pursuit of rational policymaking, based on 
using high-quality scientific evidence to reduce 
avoidable harms caused by alcohol. In such terms, 
an important series of battles have been won, 
culminating in the passage of what has become 
the Public Health (Alcohol) Act 2018. However, 
the political war will not end with legislative 
enactment. Researchers will need to focus on 
policy implementation, examining how each 
coalition seeks to advance its interests and ideas 
in this next stage of the policy process.
Anne Doyle
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of drug treatment 
services for people 
who are homeless 
and use drugs
The Irish national drugs strategy aims to improve 
access to treatment services for people who 
are homeless who use drugs and have complex 
needs. On behalf of the Department of Health, 
the Health Research Board commissioned the 
Salvation Army Centre for Addiction Services 
and Research (SACASR), the University of Stirling, 
and the Public Health Institute at Liverpool John 
Moores University to systematically review and 
synthesise the international evidence on the 
efficacy of interventions designed to serve this 
population. This synthesis will inform policies, 
currently under review, regarding the provision 
of services to people who are homeless.
This report1 comprises two parts: the first part 
presents a description of the current trends 
relating to drug use and of the services in 
Ireland in primary care, mental health, and drug 
treatment settings for people who experience 
homelessness and use drugs; the second part 
is an integrative review of the international 
research literature providing a systematic 
evaluation of the evidence on interventions that 
aim to address the needs of this population.
Introduction
People who are homeless have complex and 
challenging lives. They tend to have worse 
physical and mental health and are more likely to 
report problem substance use than the general 
population. Substance use is more prevalent 
among people who are homeless than in the 
general population and providing support 
services and drug treatment in a holistic way for 
this population should be a priority. Increasing 
the provision of evidence-based support may 
lead to improvements in health, wellbeing, and 
quality of life (QoL), and to a reduction in costs 
to healthcare and wider public services.
Overview of services in Ireland for 
people who are homeless and use drugs
There are a wide range of services in Ireland for 
people who are homeless and use drugs. These 
include health and social care services specific 
to substance use, such as counselling; drop-in 
centres; assessment and intervention advice; 
information and education; ongoing support; 
follow-up care; and a drug-screening facility. 









   












Specific programmes relevant for people who are 
homeless include the Health Service Executive 
(HSE) Social Inclusion programme, which is 
designed specifically for marginalised groups 
to help enable and improve their access to 
mainstream services. For example, the Inclusion 
Health Service at St James’s Hospital, Dublin 
attends to the complex needs of marginalised 
groups, such as people who are homeless and 
those who use drugs. Other existing services 
include abstinence-based drug treatment 
services, such as residential rehabilitation and 
harm reduction drug services (e.g. prescribing 
services, including opioid substitution therapy – 
OST); and static, pharmacy, and outreach needle 
and syringe programmes services. There are 
also housing support services across Ireland, 
such as transitional housing and emergency 
accommodation provision. It is important to 
note that many nationwide services provide a 
holistic approach to treatment and support; 
therefore, it is not possible to fit them neatly into 
service type. In particular, many third-sector 
organisations offer a range of services in order 
to best meet people’s needs. These can include 
drug treatment services, other harm reduction 
services, housing support services, and other 
more general health and social care services, 
among others.
Evidence review on effective 
interventions for people who are 
homeless and use drugs
This report is a systematic review of reviews 
and aimed to synthesise international evidence 
on effective interventions for this population. 
Twenty-two publications (18 published papers 
and four grey literature reports) published 
between 2004 and 2020 were included. Thirteen 
of the 18 publications included academic reviews 
deemed to be systematic (with two of these also 
including a meta-analysis) and five were deemed 
to be non-systematic. Twelve of the reviews 
included quantitative studies only; eight included 
different study type/mixed designs (including 
one realist synthesis); one presented a meta-
ethnography and included qualitative studies 
only; and one was a review of reviews. Ten of the 
reviews were undertaken in the United Kingdom 
(UK); four in the United States of America (USA); 
four in Canada; three in Europe (Spain, Ireland, 
and a Dutch/Belgian collaboration); and one was 
an international collaboration by researchers 
from Switzerland, the UK, and Canada. Despite 
this, nearly all of the reviews (n=19) were 
international in focus, although two reviews 
focused on the USA only and one focused on 
the UK only. Even though the focus of most of 
the reviews was international, the majority of the 
authors were based in the UK, and the majority 
of primary studies were undertaken in the USA. 
This may affect the generalisability of the findings 
to non-USA contexts.
The focus of the included reviews varied, and a 
large number of interventions were investigated. 
The largest number of reviews (n=6) focused 
on housing interventions, including Housing 
First (HF) initiatives. Of the remaining reviews, 
four focused on interventions for people 
with co-occurring serious mental health and 
alcohol/drug issues (COSMHAD); three focused 
on substance use treatment specifically; 
two investigated healthcare treatments 
and interventions in general; two focused 
specifically on case management interventions; 
one focused solely on assertive community 
treatment (ACT); one focused on sexual health 
promotion interventions; one investigated the 
impact of harm reduction interventions on the 
incidence of hepatitis C virus; one examined 
the effectiveness of intentional peer support 
(IPS) for people who are homeless; and one 
examined emergency-department-based 
interventions. The primary outcomes of interest 
were treatment engagement and retention as 
well as successful treatment completion. The 
study also synthesised information relating to 
substance use outcomes, housing outcomes, and 
‘other’ outcomes (primarily health and wellbeing 
outcomes).
Treatment engagement and retention
Treatment engagement and retention for the 
homeless population can be problematic 
regardless of intervention type. ACT can lead 
to increased engagement rates for people who 
experience homelessness and use drugs. In 
Evidence review   continued
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contrast, treatment engagement with intensive 
case management (ICM) can be low, with more 
than two-thirds of participants experiencing 
both substance use problems and homelessness 
who enrol in shelter-based ICM services 
dropping out of these programmes. There is 
some evidence to suggest that motivational 
interviewing and motivational enhancement 
therapy can increase treatment engagement 
during the short term for those experiencing 
homelessness and COSMHAD. Adherence to 
highly active antiretroviral therapy (HAART) 
among people who use drugs is comparable 
to that among people who do not use drugs; 
however, the addition of OST to HAART for those 
who use drugs increases treatment adherence 
and leads to better treatment outcomes. Data 
from studies of HF interventions suggest that 
engagement can be difficult, possibly due to 
the fact that while supported and encouraged 
through a harm reduction approach, treatment 
engagement within HF is ultimately self-
determined. 
Finally, there is evidence suggesting that the 
way in which interventions are delivered can 
play a crucial role in treatment engagement 
and retention, with compassion, warmth, and 
a lack of judgement and stigma from the staff 
supporting individuals being paramount.
Successful treatment completion
There is a lack of studies reporting on successful 
treatment completion, while (limited) data 
were only presented in two of the included 
reviews. One low-quality review presented 
evidence from four randomised controlled 
trials and one meta-analysis of a linear, rigorous 
abstinence-contingent housing approach 
(called ‘Birmingham house’), which suggests 
that treatment completion rates in such an 
approach (65% in the most recent trial) can 
be higher than the approximate 50% for social 
interventions (such as case management, 
congregate living, and vocational training), and 
comparable to those of modified therapeutic 
communities. There is some evidence that 
integrated approaches in short-term residential 
programmes (lasting six months or less) for 
people with COSMHAD were associated 
with higher rates of programme completion. 
Moreover, there was evidence that monetary 
and non-monetary incentives can increase 
completion rates of directly observed preventive 
therapy in young people with latent tuberculosis 
who are homeless; however, it was not specified 
whether they were also experiencing problem 
substance use. Also, there was some evidence 
that for people experiencing homelessness 
who also inject drugs, an accelerated hepatitis 
B virus immunisation schedule (with doses 
administered at 0, 7, and 21 days, and a booster 
at 12 months) can result in superior completion 
rates, compared with traditional schedules that 
have similar seroconversion rates. 
Evidence shows that monetary and non-
monetary incentives can increase completion 
rates of directly observed preventive therapy in 
young people with latent tuberculosis who are 
homeless; however, it was not specified whether 
they were also experiencing problem substance 
use. Lastly, integrated approaches in short-term 
residential programmes (lasting six months or 
less) for people with COSMHAD were associated 
with higher rates of programme completion.
Treatment outcomes: substance use
All the included reviews reported on some 
element of substance use outcomes and, 
overall, the results were mixed. First, there is 
a large number of intervention types available 
for people experiencing homelessness with 
concurrent substance use problems. In 
general, the greater the level of integration and 
partnership between programmes and agencies 
dealing with people who are homeless and have 
co-occurring substance use problems, the 
better the outcomes. 
Evidence suggests that harm reduction 
interventions can lead to decreases in drug-
related risk behaviour (e.g. needle sharing) in this 
population in the same way as they do for other 
groups. Co-locating a number of harm reduction 
approaches together (termed ‘full harm 
reduction’) creates additional opportunities for 
clients that can lead to better outcomes than 
single (partial) harm reduction interventions. 









   












The reviews suggested that HF does not seem 
to impact either positively or negatively on 
substance use outcomes.
Treatment outcomes: housing
Reviews which reported on housing outcomes 
largely support the HF approach in terms of 
its effectiveness in increasing housing stability 
and retention, and indicate the HF approach 
as a preferred option due to the flexibility 
and harm reduction ethos associated with it. 
However, the reviews identified some issues 
relating to programme fidelity and type of HF 
housing (scattered versus single site). There is 
also some evidence that supportive housing 
can have a positive effect on housing stability. 
Other non-housing-specific interventions can 
also have a positive effect on housing outcomes. 
Most notably, peer support interventions, with 
IPS specifically being assessed, can lead to a 
decrease in the number of homeless days and a 
reduction in relapse to homelessness. Evidence 
regarding case management interventions and 
their impact on housing outcomes is mixed and 
varies between intervention types.
Treatment outcomes: other
Some treatment outcomes that were not 
related to housing or substance use were 
reported. These related primarily to mental 
health and wellbeing outcomes, with mixed 
evidence regarding the effectiveness of the 
different interventions studied. There is some 
evidence from interventions delivered in the 
USA that permanent supportive housing for 
people experiencing homelessness and who 
have additional mental health problems can 
lead to a reduction in mental health symptoms, 
compared with a control condition. There is 
strong evidence that HF can improve measures 
of physical health in the short term for ‘housing-
vulnerable’ adults. This included moderate-
strength evidence for positive effects on 
personal wellbeing, mental health, and locality-
related wellbeing (i.e. wellbeing related directly 
to one’s living situation and conditions), with 
no effects on personal finance or community 
wellbeing being reported. There is some 
evidence that the HF congregate model (where 
all residents live in one apartment block) can 
lead to greater improvements in mental health 
and QoL than the scattered HF model (where 
residents live in various individual locations). 
Lastly, there is evidence that integration of 
services and holistic treatment for people with 
comorbidities and COSMHAD leads to better 
psychosocial and substance use outcomes.
Policy and research recommendations
People who experience homelessness and 
problem substance use are a population with 
complex needs. However, it is important to 
note that they are not a homogenous group. 
Individuals will be dealing with severe challenges 
by virtue of being homeless, but may also be 
facing concurrent issues relating to substance 
use. There are gaps in monitoring and other 
routinely reported data that would provide 
better insights into the needs of this population 
and the harms associated with substance use. 
This includes regular prevalence surveys; data on 
drug-related deaths in people who are homeless; 
and infectious disease and blood-borne virus 
prevalence monitoring in people who inject 
drugs, including data on housing needs. 
A substantial evidence base exists regarding 
effective interventions for people who 
experience homelessness and for people with 
problem substance use, but not enough research 
has been conducted focusing on the unique 
needs of people who experience both, despite 
these issues commonly co-occurring. To ensure 
needs are well met, targeted provision can be 
helpful and specific subgroups do exist within 
this wider population, for example, people 
who experience homelessness and COSMHAD, 
whose needs can be even more complex. Other 
identity characteristics, such as gender, age, 
ethnic background, and experiences of physical 
disability/physical health problems, will also have 
an impact on a person’s needs, preferences, and 
overall treatment experience. Unfortunately, 
there are few studies that focus on making 
sure that people with these very complex and 
challenging experiences are well heard. 
While people who experience homelessness 
and problem substance use experience different 
circumstances and have different needs, wants, 
Evidence review   continued
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and preferences, which are also likely to change 
over time, making listening to individuals and 
providing choice is critically important. A 
balance is therefore needed between providing 
an approach that is tailored specifically to each 
individual and delivering key components of 
evidence-based services and interventions. 
Currently, there is a lack of standardisation 
of measures and outcomes, which can make 
meaningful comparisons between different 
types of service models – and, subsequently, 
any distillation of key elements of success – 
challenging.
Regarding specific intervention types, the 
evidence suggests that the HF model supports 
a flexible harm reduction approach that enables 
referral to other services needed by the 
residents. The evidence base strongly suggests 
consistent positive housing outcomes and the 
absence of negative effects on substance use, 
alongside some evidence for positive effects 
regarding physical health and wellbeing. The 
review found that case management-type 
interventions can be effective, both when 
applied on their own and when combined 
with other interventions, such as contingency 
management, positive reinforcement or 
incentives, art therapy, and health prevention 
and promotion programmes. ACT has 
consistently produced positive effects on 
housing stability and has been found to be cost-
effective, but this model seems to be suitable 
mainly for those experiencing homelessness 
and COSMHAD. Finally, the evidence suggests 
that formal IPS can lead to positive housing, 
substance use, and wellbeing outcomes, and that 
it has the potential to have a positive impact on 
the peers who provide the support. 
For this reason, the authors of the study 
recommend the development of peer support 
interventions for people who experience both 
homelessness and problem substance use. 
However, due care must be given to planning for 
the embedding of peers in services in order to 
ensure that they are respected, valued, and offer 
meaningful support and training opportunities.
Evidence review   continued Key messages
• A lack of international research exists on 
effective interventions for people who are 
homeless and use drugs. There is also a 
lack of Irish research, in particular which 
examines this intersection in depth.
• People who are homeless and use drugs 
are not a homogenous population. More 
research, particularly qualitative research, 
should be conducted to explore the ‘missing 
voices’.
• Treatment for this population group 
should be needs-led and person-centred. 
However, most research has examined 
complete treatment interventions and 
service models, with a lack of evidence on 
the effect of tailoring these.
• Treatment failure often stems from the 
service providers not recognising the 
breadth and complexity of individual needs.
• Mindful of choice for service users, a flexible 
system which provides opportunities for 
both harm reduction and abstinence-based 
approaches is recommended.
• Consensus on outcome measures (including 
treatment outcomes and treatment 
completion indicators for this population) 
should be reached to help research 
standardisation and support meaningful 
comparisons between interventions.
• Research is required on the optimal length 
of treatment for this population. This has 
implications for practice, as research 
findings may lead to a need to secure 
funding for extended periods of treatment.
• The findings highlight the importance of 
integration between different services, 
especially for people who are homeless and 
who experience COSMHAD.
• How interventions are delivered (e.g. non-
judgemental, compassionate), providing 
choices, and respecting service users’ 










   













distress, and hope: 
drug-related 
intimidation in 
Dublin’s north east 
inner city
It has been known that drug-related intimidation 
(DRI) impacts on many Irish communities. The 
Drug-Related Intimidation Initiative (DRII) project 
was established in 2019 to examine this issue in 
Dublin’s north east inner city (NEIC). The main 
objectives of the initiative were twofold: first 
to provide support to individuals experiencing 
DRI and second to conduct research into 
these experiences to increase knowledge 
and understanding from the perspective of 
the victim, perpetrator, or both, with the final 
aim of developing good practice guidelines to 
respond to DRI (p. 6).1 In January 2021, Ana Liffey 
Drug Project (ALDP) published the final report 
of the DRII.1 The research was carried out by 
ALDP under the supervision of Dr Matt Bowden, 
School of Languages, Law and Social Sciences at 
Technological University Dublin.
Literature review
The report contained a detailed literature review 
examining a range of related topics, such as 
victims of DRI; illicit drug markets and violence; 
and drug-related crime. Several Irish studies 
were identified which either examined DRI as an 
issue or found that DRI was an issue within the 
sample examined. Within these studies several 
themes emerged:
• Low-level intimidation was evident in 
communities where drug hierarchies retained 
control.
• Low-level intimation resulted in a breakdown 
of community trust and spirit, leading to 
an exacerbation of fear and a sense of 
helplessness.
• There was unwillingness to report incidents of 
DRI to An Garda Síochána (AGS).
• There was an increased likelihood of parents 
experiencing DRI, more so mothers of those 
who use drugs, because of drug debts.
Brian Galvin
1 Miller J, Carver H, Masterson W, Parkes T, Jones 
L, Maden M and Sumnall H (2021) Evidence review 
of drug treatment services for people who are 
homeless and use drugs. HRB Drug and Alcohol 
Evidence Review 7. Dublin: Health Research Board. 
https://www.drugsandalcohol.ie/33910/
• In the reviewed research, there are 
insufficient data on treatment retention 
and completion available and/or 
synthesised.
• Housing interventions, especially HF, lead 
to improvements in housing outcomes, but 
evidence regarding HF interventions and 
health and wellbeing outcomes is mixed. 
Evidence suggests that HF does not impact 
on substance use outcomes.
• Case management-type interventions 
can be effective, but ACT seems 
suitable primarily for those experiencing 
homelessness and mental health problems 
or COSMHAD.
• Peer support interventions can lead to 
positive housing, substance use, and 
wellbeing outcomes, but care must be 
taken when embedding peers into services 
due to common challenges experienced in 
such roles. 
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• Drug activity hotspots were viewed as ‘no-go 
areas’ by residents (p. 15).
• Low-debt thresholds, such as €50, could 
result in someone becoming a target of DRI.
In Ireland, one intervention that has been 
applied is the National Drug-Related Intimidation 
Reporting Programme (NDRIRP). The NDRIRP, 
which consists of a high-ranking AGS member 
from each Garda division across Ireland, aims to 
respond to intimidation experienced by people 
who use drugs, their friends or family, or others 
that are affected within the community because 
of drug debts. A recent review of this programme 
found that while NDRIRP was shown to be a 
useful tool in supporting employees’ responses 
to unpredictable challenges, awareness of the 
programme was limited. The need to enhance 
communication between NDRIRP members and 
key stakeholders was highlighted.
Methodology
The study utilised a mixed-methods approach 
consisting of desk and field research. Initially, a 
literature review identified academic and policy 
research related to DRI. Next, a mapping exercise 
identified community services that targeted or 
were related to DRI problems in the NEIC. Finally, 
the field research was carried out and included 
three approaches:
• Online surveys were carried out via 
SurveyMonkey between June 2020 and early 
August 2020 (n=471).
• Participants (n=18) from 12 organisations 
participated in three focus groups in July 
2020.
• Semi-structured interviews were carried out 
with individuals who had direct experience of 
DRI in the NEIC (n=4).
Findings
Table 1 shows a summary of the main findings of 
the study, incorporating the online survey, focus 





Awareness of DRI issues in the NEIC was reported by 83% of survey 
respondents. Similarly, ‘deep awareness’ (p. 31) was illustrated by participants in 
focus groups and interviews
Experience of 
DRI
Nearly one-quarter of online survey respondents indicated that they had direct 
experience of intimidation (23%). Some of these experiences occurred in the 
month before the survey (32%), while for others the experience occurred in the 
previous year or over a year, 38% and 30%, respectively
Form of DRI Direct experiences of DRI took several forms: physical harm (67%; 34/51); 
movements tracked (53%; 27/51); threat of vandalism or property takeover 
(45%; 23/51); and threat of sexual violence (12%; 6/51)
Perceptions 
as to why DRI 
occurred
Individuals with direct experience of DRI put forward several reasons as to why 
they were targeted or believed they were targeted. The top five reasons were:
1. As a warning or to frighten people in the community (55%)
2. Other (51%)
3. Money owed from buying drugs (43%)
4. Under pressure to participate in drug supply or drug-related crime (43%)
5. Someone known to the respondent owed money for purchasing drugs (35%)
Debts, threats, distress, and hope  
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The top five categories identified by respondents as being most at risk of DRI 
included: people who use drugs (88%); partners of people who use drugs 
(80%); parents of people who use drugs (79%); young people (75%); people who 
sell drugs (69%)
The where of 
DRI
39% of respondents reported that DRI can take place in more than one place 
(at home, at work/school/college, at a community service, on the streets or 
other), followed by on the streets (31%) and at home (16%)
The when of 
DRI
While DRI could take place at any time, 35% indicated that it occurred between 
5pm and midnight
Perceptions 
of safety and 
community
Respondents mainly considered the NEIC area unsafe or very unsafe (41%); this 
was more so for individuals with direct experience of intimidation (76%, 38/50) 
than those who had none (36%; 126/346)
Responses to 
DRI
Reporting rates of DRI experiences were low (18%); 82% of this population 
did not report the experience to anyone. Only eight of those who reported 
the experience reported it to AGS. Several reasons were identified for not 
reporting: fear (67%); lived near to perpetrator (21%); fear for someone close 
who owed money (19%); victim owed money (19%); fear of impact on tenancy 
(19%)
Debts, threats, distress, and hope  
continued
Study limitations
As acknowledged by the authors, the 
sample self-selected and hence may not be 
representative of the NEIC population. As only 
adults took part in the survey, the views of 
children under 18 are unknown. Participants 
in focus groups and interviews self-selected 
or were put forward by their organisation. 
Qualitative interviews involved only male 
participants. The survey was carried out online, 
hence access to the internet and being able 
to work online would have been necessary to 
participate.
Guidelines
When dealing with DRI, five guidelines were put 
forward for consideration:
1 DRI is multifaceted. Hence, interventions 
need to consider what aspect of the issues is 
being targeted.
2 There is recognition that interventions 
are not neutral. Hence, the impact of the 
interventions must be considered to ensure 
that they do not unintentionally result in 
increased risk.
3 For an intervention to be successful, the 
community must be invested in its success 
and therefore needs to be placed at the 
centre of it.
4 Interventions need to be local and tailored to 
that specific location to increase buy-in from 
that community.
5 It is important to manage not solve, as there is 
no ‘quick fix’ solution to DRI. As long as illicit 
drug markets exist, violence and intimidation 
will be associated with resolving problems.
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Recommendations
Recommendations by the authors focused on 
interventions, which were categorised into two 
areas:
• Community-level interventions: These 
interventions need to be implemented within 
the NEIC community. For example, training on 
DRI; information packs on responding to DRI; 
increased awareness of NDRIRP; empowering 
local residents to address DRI; and support 
policing in the local community. The DRII 
can action some of these without additional 
resourcing. However, other interventions will 
need more resourcing and commitment to 
implement.
• Policy-level interventions: These 
interventions are beyond the remit of 
community operations and policies will need 
to be progressed at a national level. For 
example, areas to be explored include:
-  The current regulatory framework 
controlling drugs needs to be examined 
to assess whether it is fit for purpose or 
whether more regulation is needed to 
control supply.
-  Interventions are needed to target young 
people at risk, with the aim of preventing 
or delaying entry into the drug market.
-  DRI affects marginalised communities 
the most. Policymakers therefore need 
to determine whether existing systems 
support those that experience challenges 
such as poverty, stigma, or lack of 
opportunity.
Conclusion
The work that went into the report was 
commended by Minister for Finance, Pascal 
Donohue TD. While Minister Donohoe 
acknowledged the importance of involving 
leadership and interagency partnership, 
he emphasised that the voices of the local 
community who are facing intimidation were 
needed to inform how to tackle the problem.  
In agreement, Tom Duffin, CEO of ALDP, 
reiterated how DRI impacted on communities 
along with the complexity of the problem:
It’s easy to think of drug-related intimidation 
as a purely transactional issue – people get 
into debt from drug use and then experience 
intimidation as suppliers seek to recover their 
money. However, what this work shows is that 
drug-related intimidation is more complex 
than this; and that in reality, even living in a 
location where dealing takes place can be 
sufficient for a person to become a target 
of intimidation. The sad truth is that many 
people do not feel safe in their communities, 
and this is something that we should all have 
an interest in addressing.2
Ciara H Guiney
1 McCreery S, Keane M and Bowden M (2021) Debts, 
threats, distress and hope: towards understanding 
drug-related intimidation in Dublin’s north east 
inner city. Dublin: Ana Liffey Drug Project.  
https://www.drugsandalcohol.ie/33682/ 
2 Ana Liffey Drug Project (2021) Report highlights 
need to work together to address drug-related 
intimidation [Press release]. Dublin: Ana Liffey Drug 














   











21 Lifting the lid on 
Bluetown and 
Redtown
On 27 January 2021, Minister for Justice Helen 
McEntee TD launched ground-breaking research 
carried out by the Research Evidence into Policy 
Programmes and Practice (REPPP) Project team 
at the University of Limerick. Overall, there were 
three reports: Lifting the lid on Bluetown,1 Lifting 
the lid on Redtown,2 and a national prevalence 
study.3 This article presents a synthesis of the 
Bluetown and Redtown studies.1,2
Background
The Bluetown and Redtown studies are two 
replication case studies carried out to determine 
whether the findings of the Greentown study 
could be generalised to other locations in 
Ireland.4,5 The original Greentown study in 2016 
examined the effect of a criminal network on 
offending behaviour of children.4,5 The results of 
this study indicated that a criminal network was 
in operation in Greentown and responsible for 
enabling increased criminal activity in children 
in this area. Five main findings emerged in the 
Greentown study:
1 A criminal network existed and contained key 
network actors.
2 The network was hierarchical in nature.
3 The hierarchical structure was supported 
by powerful processes and a sympathetic 
embedded culture.
4 Power and influence were mediated by 
geography, obligation, and the intensity of the 
relationships with patrons.
5 The network compelled some children in 
the area into abnormal patterns of offending 
behaviour (p. 10).4
Aims of replication study
The aim of the replication case studies was to 
determine what factors influence young people’s 
engagement and retention within a criminal 
network and how these factors may influence 
their crime trajectories. The main research 
questions addressed in this study included:
1 From the Garda respondents’ perspective, 
what are the factors that influence young 
people’s engagement and retention within the 
Bluetown/Redtown criminal network?
2 How do members of An Garda Síochána 
portray the influence of engagement in 
the Bluetown/Redtown network on young 
people’s patterns of crime?
Methodology
Similar to the Greentown study, the Bluetown 
and Redtown studies were centred on a case 
study design and consisted of the following 
sequential steps:
• Burglary and drugs for sale and supply 
detection data for offences committed by 
young people (aged <18 years) and collated 
on An Garda Síochána’s PULSE (Police Using 
Leading Systems Effectively) system between 
2014 and 2015 were analysed and ranked.
• A criminal network map was developed by 
Garda analysts using the PULSE data and 
illustrated how offenders who carried out 
burglary or drugs for sale and supply and 
robbery offences between 2014 and 2015 
in Bluetown/Redtown linked together via 
common offences.
• To ensure anonymity of individuals on the 
criminal network map, Twinsight methodology 
developed for the Greentown study was 
utilised.4 Two versions of the map were 
developed: a ‘live’ version and a ‘researcher’ 
version. The live version contained personal 
details of the offenders involved and was 
only seen by Garda members or analysts. The 
second version, a researcher version, was 
similar to the first version, except there was 
no identifying or personal information and 
was used only by the researcher. The maps 
shared unique identifier codes, which allowed 
Garda respondents (n=16) taking part in semi-
structured interviews to ‘ground’ (p. 24) their 
views by linking real events to the individuals 
on the map via the unique identifier.4
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• Garda respondent interviews focused on 
network members and contexts and were 
embedded in specific events.
• Transcribed interviews were imported into 
NVivo software, where they were coded and 
analysed.
• Two quantitative diagnostic tools were used 
to identify and develop case profiles of 
significant members within the network.
• The themes found increased the 
understanding of how the network operated.
Bluetown study
Findings
Bluetown was a large urban Garda subdistrict.1 
Findings from the Bluetown study were grounded 
in Garda narratives and centred mainly on their 
significance to the research questions. Three key 
findings emerged from the analysis.
Finding 1: Four area-based criminal networks 
existed in Bluetown that were distinct from 
each other.
Of the four criminal networks identified, 
three were operational (Area A, Area B[n=2], 
and Area C). Individuals living in Area D were 
no longer considered involved in crime. The 
criminal network map was adapted to show key 
differences between locations and networks that 
emerged in Garda narratives. Bluetown covered 
a larger area than the Greentown and Redtown 
studies. The impact of this was that Garda 
respondents could only provide information 
regarding areas they patrolled. Table 1 shows 
a summary of networks and some of their key 
characteristics.1
Themes Network Characteristics
Area A Network 1 • Family based and hierarchical in nature and has existed for 
generations
• Led by husband-and-wife team, B46 and B55
• Members included their sons (B54 and B56) and extended family 
(B43, B44, B45, B47, B48, B53)
• Focused on property crime
• Considered a ‘massive organisation’ (p. 22)
• Proceeds of crime given to the family
• Network was structured with a level of organisation
• Viewed as intergenerational career criminals 
Area B Network 2 • Emerging crime gang centred on five members (B11, B7, B5, B12 
and B5) living near each other
• No family ties
• Centred on peer and ‘associate’-based relations (p. 27)
• Initially committed minor offences, moved on to more complex 
burglaries and assault and robbery as they aged
• 3/5 members were serving long prison sentences at time of study
Lifting the lid on Bluetown and 
Redtown   continued









   













Area B Network 3 • Highest level of burglary detections
• Consisted of five core members who grew up together (B21, B19, 
B17, B20 and B10)
• Responsible for violent and aggravated burglaries
• Internal group friendship and trust sustained network in the area
• Considered a ‘dangerous crew’ (p. 29)
• 4/5 members (B21, B10, B17 and B19) were in prison at time of 
study
Area C Network 4 • Close-knit group of friends who lived near to one another
• Those involved included retail-level drug street dealers, those 
carrying the drugs, those vulnerable, and those at risk of being 
caught
• G24, the network’s leader, did not exist on the network map
Area D – • Individuals no longer participated in serious or atypical crime 
except for one (B29)
• Information emerged via a common robbery incident
• Desistance from crime evident
Lifting the lid on Bluetown and Redtown   continued
Finding 2: A combination of risk factors was 
linked to young people developing more 
serious and prolific offending patterns across 
all networks.
A thematic analysis showed a relationship between 
‘shared common risk factors’ and ‘more serious 
and prolific offending patterns’ in all identified 
networks (p. 39).1 There were four subthemes:
• Family ties to crime
• Proximity to a network of offending peers
• Individual risk factors
• Pro-criminal norms.
Finding 3: Criminal network strength and 
stability was enhanced by the quality of 
‘trust’ in relationships between members and 
influenced by fear and intimidation.
Based on thematic analysis, relationship strength 
between network members was shown to have 
varying levels; higher levels of trust contributed to 
greater network stability, as shown in Figure 1.
• Network 1 is strongest with regard to 
relationship strength and network stability.
• Networks 2 and 3 were centred on co-
offending relationships that emerged from 
living near to each other and other risk 
factors.
• Network 4 was centred on a drugs hierarchy 
and utilised a more organised structure.
• Fear and intimidation contributed to the 
strength and stability of Bluetown networks.
Source: O'Meara Daly, Redmond and Naughton (2020)1
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Figure 1: Network position from low strength and stability to high
Lifting the lid on Bluetown and Redtown   continued
Source: Figure 11 extracted from O’Meara Daly, Redmond and Naughton (2020), p. 431
Strengths and limitations
There were several strengths and limitations to 
the study. The findings in this study were centred 
on third-party observations and perspectives. 
The Twinsight methodology developed in the 
Greentown study allowed for in-depth knowledge 
and context to be captured. However, there were 
challenges, as the area covered by Bluetown was a 
large urban area. As a result, knowledge reported 
by Garda respondents was limited and centred on 
their own patrol or catchment area; hence, some 
information on offenders was from a broader 
perspective rather than focused on specific 
individuals. As acknowledged by the authors, similar 
to the Greentown study, there were limitations 
to utilising PULSE data to develop the map.6,7 
Nevertheless, Garda respondents believed that the 
map was accurate, giving it an average rating of 8.36 
out of 10 for accuracy (p. 48).1
 
Redtown study
The Redtown study was of a small provincial town. 
It was ranked third in the Garda subdistricts list 
because of the number of youths aged under 18 
years involved in burglary and drugs for sale and 
supply. Hence, this location was considered ideal to 
enable a deep exploration of the factors that may 
contribute to criminality in this cohort.2
Findings
The analysis of Garda respondent narratives 
resulted in two main themes emerging: family 
influences and drug-related crime. Each will be 
described separately.
Theme 1: Family influences – adversity,  
pro-criminal norms, and exclusion
Three young people, aged 16 years, who were 
repeatedly involved in burglary offences between 
2014 and 2015 along with their engagement with 









   












of Garda narratives. Criminal activity was mainly 
viewed as normal by their peers and more so 
by their families who had criminal histories. The 
main characteristics of the family were that they 
were of low status, experienced financial poverty, 
and had high levels of adversity. In addition, 
families were rooted within the Redtown criminal 
network via ‘extended family and drugs-related 
links’ (p. 16).2 These young people had a tendency 
to be excluded from the mainstream Redtown 
community. These factors together influenced 
young people’s involvement with both criminality 
and the Redtown criminal network.
Theme 2: Drug-related crime – organised or 
chaotic
Drug-related offences were the main activity 
carried out by the Redtown network. How 
a network member was involved and the 
organisational level of the drug-related offence 
centred on how vulnerable the individual was 
and their personal drug use (p. 16).2 Three 
interconnected groupings were identified:
• Fund personal use (chaotic)
• Carrying and distribution of drugs
• Organised.
‘Organised’ network members mainly carried out 
‘higher-level sale and supply’ (p. 16)2 and remained 
‘undetected’ on the network map. While most 
of the network members could be classified as 
‘chaotic’, they carried out lower-level sale and 
supply of drugs and other crime to pay for drugs 
for personal use. This group are considered 
susceptible to exploitation. Figure 1 provides a 
summary of the theoretical framework the authors 
put forward showing the interconnections between 
themes, subthemes as processes of engagement, 
and retention of network membership. Further 
detail on the key network members can be found 



















Figure 2: Network membership theoretical framework for Redtown
Source: Figure 16 extracted from Naughton, Redmond and O’Meara Daly (2020), p. 402
Lifting the lid on Bluetown and 
Redtown   continued
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Strengths and limitations
Several strengths and limitations were identified. 
For example, due to the level of young people 
involved in criminality in Redtown, it was 
viewed as an ‘untapped source’ (p. 41).2 The 
Twinsight method allowed for both group and 
individual level analysis to be applied. Moreover, 
this approach allowed for the network to be 
examined longitudinally, both before and after 
the 2014–2015 timeframe. Garda respondents 
were advised that the focus was on young 
people, which may have influenced their 
responses. Despite this, the intergenerational 
nature of offending behaviour was evidenced by 
the involvement of older family members in the 
network. More methodological strengths and 
limitations can be found in all three Greentown 
Project reports.1,2,4
Conclusion
The aim of these studies was to explore whether 
criminal networks influenced children moving 
into a life of crime. The results are believed to 
provide hope and opportunities for children 
drawn into serious and prolific crime. Minister 
McEntee thanked Dr Sean Redmond and his 
colleagues for their work and acknowledged the 
importance of breaking the connection between 
criminal networks and young people. The 
Greentown Project has provided the information 
needed to help prevent young people from 
becoming part of these networks. She noted that 
the research evidence shows the seriousness 
of this issue and requires a ‘serious and rapid 
criminal justice response’ (p. 1).8
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21 Correlates of 
cannabis use and 
cannabis use disorder 
in Ireland
Background and methods
The prevalence of cannabis use has increased 
in many developed countries in recent years. In 
the Republic of Ireland, the most recent national 
survey, conducted in 2014/15, found that 27.9% 
of people aged 15–64 years had used cannabis 
at some point in their lives, with 7.7% and 4.4% 
having used cannabis within the last year or last 
month, respectively.1 Concurrent with higher 
rates of use, the number of people entering 
treatment for a cannabis use disorder (CUD) has 
also increased; in Ireland, for new entrants to 
treatment in 2017, cannabis replaced opiates as 
the most commonly reported primary problem 
drug.2 Cannabis is also now the most common 
substance involved in drug-related admissions 
to psychiatric hospitals in Ireland.3,4 As proposals 
to liberalise cannabis laws are currently being 
explored in many countries, knowledge of factors 
relating to patterns of cannabis use and CUD is 
important for informing drug policy.
A new Irish study5 determined factors associated 
with recent and current cannabis use and having 
a CUD – defined as abuse or dependence 
using the Diagnostic and Statistical Manual 
of Mental Disorders (DSM-5). In this research, 
published in the European Journal of Public 
Health, data were analysed from Ireland’s 
2010/11 and 2014/15 National Drug Prevalence 
Surveys, which recruited 5,134 and 7,005 
individuals, respectively, aged 15 years or 
more, living in private households. Multinomial 
logistic regression was used to identify factors 
associated with recent (last-year) and current 
(last-month) cannabis use compared with ever 
cannabis use. Binary logistic regression was used 
to determine factors related to CUD among 
current cannabis users.
Results
The weighted prevalence of ever cannabis use 
for the combined surveys was 18.3%, with 3.0% 
and 3.3% of participants indicating recent or 
current use, respectively. Twenty-four per cent 
of recent users and 41.3% of current users 
scored positive for a CUD – either cannabis 
abuse or dependence. In multivariable analysis, 
factors associated with both recent or current 
cannabis use included younger age, not having 
dependent children, and current use of tobacco 
or alcohol. In addition, a positive attitude 
towards cannabis legalisation was found to be 
significantly related to both recent and current 
use. Regarding problem cannabis use, key 
findings were that the odds ratio (OR) of having 
a CUD was higher among males (OR=2.01, 95% 
CI: 1.13–3.57); participants aged 25–34 (OR=1.88, 
95% CI: 1.04–3.39) and those aged 15–24 years of 
age (OR=4.22, 95% CI: 2.11–8.46); and individuals 
who had very low educational attainment levels 
(OR=3.62, 95% CI: 1.93–6.77).
Conclusions
The authors noted that the high prevalence of 
CUD among current users found in this study is 
concerning but not unexpected, as research has 
demonstrated that greater frequency of cannabis 
use increases the likelihood of developing 
problematic use. Consequently, these findings do 
suggest that health professionals should have a 
high level of suspicion regarding the possibility of 
a CUD where current cannabis use is reported. 
Given the potential public health implications 
of cannabis legalisation, it is imperative that 
valid and reliable information on cannabis use, 
CUD, and cannabis-related harm is collected to 
ensure that the impact of any changes arising 
from cannabis legalisation can be accurately 
measured. The authors suggest that findings from 
this study may be used to better inform public 
health efforts to improve prevention of CUD and 
in the identification and referral of CUD clients 
to appropriate treatment services.
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Factors associated 








Opioid use disorder (OUD) is a significant 
contributor to morbidity and premature 
mortality and represents a major public health 
problem worldwide. Drug overdose is the 
leading cause of death among people with 
OUD and interventions such as opioid agonist 
treatment (OAT) have been widely implemented 
to circumvent preventable fatalities within this 
population.1 Methadone maintenance treatment 
(MMT) is the most common OAT in Ireland and 
has been shown to be cost-effective, safe, 
and beneficial in reducing risk behaviour and 
improving health and social outcomes.
Despite the strong evidence base supporting 
the use of MMT, during the first four weeks of 
treatment initiation and following treatment 
cessation, the mortality risk for clients remains 
high.2 This risk is reduced if individuals are 
retained in MMT, therefore, efforts to improve 
retention are essential. A 2020 systematic 
review demonstrated that retention rates in 
MMT decrease over time, with most dropouts 
occurring early in treatment, and a number of 
factors that influence retention were identified.3 
However, despite clients often transitioning 
in and out of treatment, most of the studies 
included did not consider these risk factors as 
time-varying covariates and also failed to model 
the time to dropout of successive treatment 
episodes as recurrent event data.
In a 2021 research paper, published in the 
journal Drug and Alcohol Dependence,4 the 
authors conducted an observational cohort 
study of individuals who had experienced at 
least one episode of MMT lasting greater than 
seven days in Irish specialist addiction services 
(Dublin Southwest and Kildare) between 1 
January 2010 and 31 December 2015. Data were 
gathered through the Central Treatment List 
and the Methadone Treatment Scheme. Client 
records were also linked to the General Medical 









   












and the National Drug-Related Deaths Index. 
Using a statistical model, this study identified 
determinants of time to dropout of MMT at 
three months and at 12 months across multiple 
treatment episodes.4
Results
The 2,035 clients included in the study 
experienced a total of 4,969 MMT episodes over 
the observation period. The median age was 34 
years at the time of initial treatment episode 
and 68% were men. Almost 42% of clients 
received a median methadone dose below the 
recommended optimal range of 60–120 mg/day. 
The study observed:
• 2,724 dropout events occurred during the six-
year observation period.
• 82.8% of all dropouts occurred within the first 
12 months of treatment.
• 49.7% of dropout events occurred in the first 
three months.
Dropout at three months was associated with 
low dose methadone (<60 mg/day) and a history 
of previous dropout. Adherence to treatment, 
defined as not missing doses over the previous 
30 days, was shown to be protective. Low dose 
methadone and previous dropout remained as 
increased risks of dropout at 12 months. Being 
male, having a prescription for benzodiazepines, 
and a higher number of comorbidities were 
also identified as additional risk factors in the 
longer-term model. Once again, adherence was 
protective at this time point.
Conclusions
The factors identified in this study could serve 
as indicators to risk stratify clients and provide 
service enhancements to increase engagement 
and retention in treatment. Previous dropout or 
missing doses are suggestive of instability and 
these clients should be identified as high risk 
of both early and later dropout. It is noted that 
no study thus far has examined the persistent 
prescribing of low dose methadone, but it is 
suggested by the study authors that a review 
of prescribing practices should be considered. 
Adherence was protective at three and 12 
months and should be actively encouraged. 
The authors recognise both the strengths and 
limitations of this current research and note 
that further testing and validation is required 
to build on the associations identified here in 
understanding the determinants of dropout from 
OAT.
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Approaches to addiction treatment remain a 
source of ongoing policy debate worldwide. 
Advocates for a recovery-focused approach have 
questioned the dominance of harm reduction 
strategies, particularly in regard to their record 
in social integration and other non-treatment 
outcomes, such as employment and education. 
Traditionally, some recovery advocates have 
argued that an abstinence-centred system best 
serves the social reintegration of its clients.1 
Critics of this outlook have insisted that it is 
limited given the wide range of other personal 
and socioeconomic challenges faced by people 
who use drugs, and that it is grounded more in 
ideology than scientific evidence.2 Currently, 
there is an accommodation between the two 
perspectives, whereby most supporters of 
recovery do not view drug-based treatment as 
inimical to the goal of social reintegration and a 
fulfilling life.
In Ireland, the authors of a 2005 study assert 
that a covert implementation of harm reduction 
strategies occurred in response to the opiate 
epidemic and emergence of HIV in the 1980s.3 
Irish drug policymaking has since given way 
to a more transparent process through the 
introduction of national drug strategies and 
has shifted towards an aspirational focus on 
‘rehabilitation’. Although differing slightly in 
terminology, this rehabilitation framework 
largely reflects the recovery concept of other 
jurisdictions. The current drugs strategy is 
characterised by two main themes: integrated 
care pathways that provide a journey towards 
recovery and service provision that is respectful 
to clients and promotes their involvement as 
active partners in the planning and delivery of 
their care.4
A 2021 research paper, published in the 
International Journal of Drug Policy, examined 
how the lived experiences of service users on 
long-term methadone maintenance treatment 
(MMT) compare with Ireland’s current drug policy 
goals.5
Methods
In-depth qualitative interviews were recorded 
with 25 long-term clients who had been enrolled 
in MMT at least 10 years prior to participating 
in the study. Recruitment focused primarily 
on clients of specialist addiction clinics in the 
Dún Laoghaire-Rathdown area of South Dublin. 
The interviews were topic-centred but allowed 
flexibility to accurately capture service users’ 
personal experiences. Analysis was guided by a 
grounded theory approach and thematic analysis 
was used to identify patterns within the data 




Most of the study participants reported 
that MMT had positively impacted one or 
more aspects of their lives, with the benefits 
concentrated on providing a sense of stability 
and normality. Clients reported such stability 
had resulted in better management of daily life 
and responsibilities, more positive engagement 
with children and family, and improved health 
and wellbeing. Male interviewees particularly 
recounted a reduction in criminal activity and 
contact with the criminal justice system.
Inability to progress
While MMT promoted daily stability, a journey 
to recovery was not reflected in the accounts 
of the study participants. Individuals generally 
described their circumstances as stagnant with 









   












respondent described treatment as ‘stalling’ 
rather than ‘fixing’ the problem and many 
expressed feelings of being trapped in a cycle, 
with references to ‘liquid handcuffs’ and being 
held ‘hostage’, highlighting the perception of 
an unending process rather than a pathway to 
recovery.
Lack of involvement and control
Negative viewpoints towards the treatment 
setting were also conveyed by respondents, 
with a perceived lack of caring or interest 
shown in the personal circumstances, issues 
or challenges faced by the service user. Study 
participants depicted a sense of passivity in 
their care and felt there was little opportunity to 
provide input or influence their treatment plan. 
One interviewee explained: ‘They’re giving out 
maintenance too quick [without] asking “What 
do you think?”.’ Participants drew attention to a 
particular unwillingness of prescribing doctors to 
lower the clients’ daily dose, with such requests 
viewed negatively or refused without detailed 
explanation or engagement in discussion. 
Several respondents described the difficulty 
in establishing trust with doctors in the clinic. 
Overall, the ability to exert agency over their 
treatment was largely absent in the experiences 
recorded for this research.
Obstacles to reintegration
Several barriers to social reintegration were 
expressed by participants, most of whom were 
unemployed at the time of interview. Many felt 
the labour market was generally out of reach due 
to low educational qualifications, stigmatisation, 
and concerns around balancing MMT with 
employment. Daily life for interviewees was often 
depicted by feelings of isolation and loneliness, 
with family relationships remaining tenuous, 
difficulty maintaining friendships, and lacking a 
sense of belonging in their communities. One 
interviewee explained how he found it ‘pretty 
hard to reintegrate into normal society’, with the 
same sentiments of marginality shared among 
the majority of study participants.
Conclusions
The authors conclude that there is a clear 
disparity between Irish drug policy aims of 
recovery and social reintegration and the lived 
experiences of those who are long-term MMT 
clients. Participants did not view themselves on 
a pathway to rehabilitation and that the current 
system did not facilitate client input or autonomy 
over their ongoing care, while reinforcing feelings 
of social exclusion and stigmatisation. This 
study indicates that the current rehabilitation 
framework has not yet delivered improved 
outcomes for opioid-dependent clients and 
practices of service-user involvement have not 
been meaningfully implemented. To improve the 
quality of life for service users, a more realistic 
policy approach is urgently needed.
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PREVALENCE AND CURRENT SITUATION
Self-harm in  
Irish prisons
The Self-Harm Assessment and Data Analysis 
(SADA) Project was set up in Ireland in 2016 
to provide robust information relating to the 
incidence and profile of self-harm within 
prison settings as well as individual-specific and 
context-specific risk factors relating to self-
harm. In addition, it examines patterns of repeat 
self-harm (both non-fatal and fatal). The Health 
Service Executive’s National Office for Suicide 
Prevention and the National Suicide Research 
Foundation assist the Irish Prison Service with 
data management, data analysis, and reporting. 
This article highlights findings from a report 
presenting data in the analysis of all episodes of 
self-harm across the Irish prison estate during 
the year 2018.1
Episodes of self-harm
Between 1 January and 31 December 2018, there 
were 263 episodes of self-harm recorded in Irish 
prisons, involving 147 individuals. The majority of 
prisoners who engaged in self-harm were male 
(82.3%), but taking into account the male prison 
population, the rate of self-harm among males 
was 3.4 per 100 prisoners. Twenty-six female 
prisoners engaged in self-harm in 2018, equating 
to a rate of 19.3 per 100 prisoners, which is 5.7 
times higher than the rate among male prisoners.
Methods, severity, and intent
The most common method of self-harm 
recorded was self-cutting or scratching, 
which was present in 69% of all episodes. 
The other common method of self-harm was 
attempted hanging, which was involved in 20% 
of episodes. In 27% of self-harm episodes, no 
medical treatment was required, while over 
one-half (59%) of all episodes required minimal 
intervention/minor dressings or local wound 
management. One in eight episodes required 
hospital treatment (12%). Over two-thirds (70%) 
of self-harm episodes were recorded as having 
no/low suicidal intent, with 17% recorded as 
having medium intent. Approximately one in 
eight acts was rated as having high suicidal intent 
(13%).
Contributory factors
The most common contributory factors to 
self-harm are shown in Figure 1. The majority of 
contributory factors recorded related to mental 
health (45.6%). The category of mental health 
issues included mental disorders as well as 
problems with coping and emotional regulation. 
Substance misuse, including drug use and drug 
seeking, was the next most common factor 
recorded (16.3%). 
Other findings and recommendations
Other findings highlighted in the report include 
the following:
• Three-quarters (73%) of self-harm 
episodes involved prisoners in single cell 
accommodation. Considering the overall 
prison population, 51.9% of prisoners who 
self-harmed were accommodated in single 
cells in 2018.
• The rate of self-harm was higher among 
prisoners on remand or awaiting trial than 
among sentenced prisoners (5.0 vs 3.7 per 100 
prisoners).
• In line with previous findings, substance 
abuse continues to be one of the primary 
factors associated with self-harm among 
the prison population in Ireland. The report 
authors suggest that there is a need for active 
consultation and collaboration between 
the mental health services and addiction 
treatment services for prisoners who present 
with dual diagnoses in line with action 2.1.24 
of Reducing harm, supporting recovery 
to ‘improve outcomes for people with co-










   











21 Self-harm in Irish prisons   continued
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Figure 1: Most common contributory factors to self-harm in Irish prisons, 2018
Source: McTernan et al. (2020)
Seán Millar
1 McTernan N, Griffin E, Cully G, et al. (2020) Self-
harm in Irish prisons 2018: second report from the 
Self-Harm Assessment and Data Analysis (SADA) 
Project. Dublin: Irish Prison Service. 
https://www.drugsandalcohol.ie/32840/
2 Department of Health (2017) Reducing harm, 
supporting recovery: a health-led response to 
drug and alcohol use in Ireland 2017–2025. Dublin: 
Department of Health.  
https://www.drugsandalcohol.ie/27603/
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Irish drug 
quantification 




Forensic Science Ireland (FSI) is an associated 
office of the Department of Justice delivering 
comprehensive scientific analysis, independent 
expert opinion, advice, and training to support 
the Irish criminal justice system. The analysis of 
substances that are suspected to contravene 
the Misuse of Drugs legislation comprises the 
majority of submitted cases to FSI. Analysis 
of these cases is carried out by the Chemical 
Analysis Department in FSI and cases range in 
both content and complexity.
The Chemical Analysis Department contributes 
to the European Union (EU) Early Warning System 
for the reporting of emerging drug trends via 
the European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA), the drugs working 
group in the European Network of Forensic 
Science Institutes (ENFSI), and the Early Warning 
and Emerging Trends (EWET) group in Ireland. 
The majority of drugs cases brought to FSI are 
submitted by An Garda Síochána (AGS) and, in 
addition to the reporting of these cases, FSI 
provides intelligence data to AGS. These data 
support the understanding of the illicit drug 
market in Ireland and include quantification data 
for some of the most commonly seized materials.
Quantification data are produced for intelligence 
purposes for three substances: cocaine, 
diamorphine (heroin), and amphetamine. Data 
are presented below. These were the second, 
third, and tenth most commonly seized drugs, 
respectively, in 2019.1 The data also include 
the most commonly identified adulterants. 
An adulterant is defined as any extraneous 
substance found in addition to the analyte 
of interest. Two distinct levels of seizure are 
analysed for quantification of cocaine and 
diamorphine: street level and importation 
level. Street-level samples are defined as those 
submitted from seizures less than 30 g, primarily 
between 25 and 30 g, while importation-level 
samples are defined as those submitted from 
seizures primarily over 500 g. For amphetamine, 
all seizures over 25 g were quantified.
Cocaine
Cocaine was the most commonly seized 
stimulant in Ireland across the four-year period 
(2016–2019) examined and the second most 
commonly identified compound after cannabis 
in FSI in 2019.2–6 In 2019, 26% of all drugs cases 
analysed in FSI contained cocaine, which was 
equivalent to 222 kg of powder/substance.1 
Figure 1 illustrates the annual average cocaine 
content during the time period examined. The 
content has remained broadly consistent over 
the four-year period, with an increase at street 
level noted. European data support the increase 
in cocaine content seen in Ireland over the time 
interval detailed in this report. An increase in 
trafficking routes, supply, seizures, and seizure 
volumes are noted in this time period, ultimately 
leading to an increase in cocaine content 
for users.2 The importation-level content is 
consistently higher than the average at street 
level.
In the three analytes examined as part of the 
quantification project, cocaine demonstrates 
the widest variety in adulterants. Figure 2 depicts 
the range of compounds detected as part of the 
submitted cocaine samples. With the exception 
of 2017, benzocaine is the most commonly 
detected adulterant across the time period, 
closely followed by levamisole. Some of the 










   













































Figure 1: The average cocaine content at street and importation level, 2016–2019












Percentage of samples (%)
Figure 2: Comparison of the adulterants in submitted cocaine samples across street-level and 
importation-level seizures, 2016–2019
Irish drug quantification trends   
continued
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Irish drug quantification trends   
continued
Diamorphine (heroin)
Diamorphine is a semi-synthetic product 
produced by the acetylation of morphine, 
which occurs as a natural product in opium. The 
drug is controlled in the Republic of Ireland. 
Diamorphine is the most commonly encountered 
opioid in Ireland and throughout the EU and was 
the third most commonly identified compound 
in FSI in 2019.2–6 In 2019, 15% of all drug cases 
analysed in FSI contained diamorphine, which 
was equivalent to 50 kg of powder/substance.1 
Figure 3 shows the annual average diamorphine 
content over the four-year period. Some  
year-to-year variability is noted, with the 
importation-level average content higher than 
street-level. A stable supply of diamorphine 
from established trafficking routes is consistent 
with data from other European countries.2 The 
diversifying opioid market worldwide, specifically 
in North America, has largely evaded the EU, 
which is also the case in Ireland.
Caffeine and paracetamol are the most 
commonly detected adulterants in diamorphine 
seizures. Caffeine and paracetamol were found 
together in 49.5% of all samples analysed as part 
of the quantification project over the four-year 
period; this figure is higher at street level (64.1%) 
than at the importation level (42.5%). Other 
adulterants detected by the FSI method include 
clotrimazole and MDMA.
Amphetamine
Amphetamine is the second most commonly 
encountered phenethylamine in Ireland, 
after MDMA. It was the tenth most commonly 
identified compound in FSI in 2019.1 In 2019, 
2.5% of all drugs cases analysed in FSI contained 
amphetamine, which was equivalent to 27 kg of 
powder/substance. Figure 4 illustrates the annual 
average amphetamine content over the four-
year period. Average amphetamine content has 
remained broadly consistent over this time. EU 
regulations have largely focused on the control 
of precursor chemicals as the manufacture of 
amphetamines are generally local to the supply 
chain. A decrease from 2018 onwards after a peak 









































   












controls to precursor chemicals such as alpha-
phenylacetoacetamide (APAA) and derivatives 
of benzyl methyl ketone (BMK); a similar decline 
was noted in 2013 after similar controls were 
introduced in Europe.2
Caffeine is by far the most consistently detected 
adulterant in amphetamine seizures. In terms of 
adulterants, 86.25% of samples submitted for 
analysis over the four-year period were found 
to contain at least one adulterant. In the case 
of adulterated samples, caffeine was always 
detected.
Sarah Hanniffy and Yvonne Kavanagh
1 Forensic Science Ireland Case Data 2019 
(unpublished).
2 European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) (2019) European drug report 
2019: trends and developments. Luxembourg: 
Publications Office of the European Union.  
https://www.drugsandalcohol.ie/30619/


























Figure 4: The average amphetamine content, 2016–2019
3 An Garda Síochána (AGS) (2017) An Garda Síochána 
annual report 2016. Dublin: AGS.  
https://www.drugsandalcohol.ie/27780/
4 An Garda Síochána (2018) An Garda Síochána 
annual report 2017. Dublin: AGS.  
https://www.drugsandalcohol.ie/29532/
5 An Garda Síochána (2019) An Garda Síochána 
annual report 2018. Dublin: AGS.  
https://www.drugsandalcohol.ie/32192/
6 An Garda Síochána (2020) An Garda Síochána 
annual report 2019. Dublin: AGS.  
https://www.drugsandalcohol.ie/33478/
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Cannabis use among 
Irish children: results 
from the 2018 Health 
Behaviour in School-
aged Children Survey
The first Health Behaviour in School-aged 
Children (HBSC) Survey was conducted in Ireland 
in 1998 and has been repeated every four years 
ever since. In 2018, the study was conducted in 
Ireland for the sixth time. This survey included 
15,557 children aged 8 to 18 years, drawn from 
a representative sample of 255 primary and 
post-primary schools across Ireland. Data 
were collected on general health, social class, 
smoking, use of alcohol and other substances, 
food and dietary behaviour, exercise and physical 
activity, self-care, injuries, bullying, and sexual 
health behaviours. Social class corresponds to 
high, middle, and low social class groups. The 
categories used for social class are standard 
and were determined by the highest-reported 
parental occupation. High social class includes 
professional occupations (i.e. solicitor, doctor), 
and managerial occupations (i.e. nurse, teacher); 
middle social class includes non-manual 
occupations (i.e. sales person, office clerk) and 
skilled-manual occupations (i.e. hairdresser, 
carpenter); low social class includes semi-skilled 
occupations (i.e. postal worker, carer) and 
unskilled occupations (i.e. cleaner, labourer). The 
main results were published in January 2020.1 
Published findings regarding cannabis use are 
shown below.
Last-year cannabis use among Irish 
school-aged children
Statistically significant differences by sex and 
age group were observed for last-year cannabis 
use. Overall, 8% of boys and 6% of girls reported 
cannabis use in the last 12 months. Younger 
children were less likely to report cannabis use 
in the last 12 months than older children. No 
statistically significant differences across social 





































Figure 1: Percentage of 12–17-year-olds reporting use of cannabis in the past year, 2018









   











21 Cannabis use among Irish 
children   continued
Current use of cannabis among Irish 
school-aged children
Statistically significant differences by sex and 
age group were reported for current use of 
cannabis. Overall, boys (4%) were more likely 
than girls (3%) to report cannabis use in the last 
30 days. Younger children were also less likely 
to report cannabis use in the last 30 days than 
older children. As with last-year cannabis use, no 
statistically significant differences across social 
class groups were found (see Figure 2).
Seán Millar
1 Költő A, Gavin A, Molcho M, Kelly C, Walker L and 
Nic Gabhainn S (2020) The Irish Health Behaviour 
in School-aged Children (HBSC) study 2018. Dublin: 
Department of Health and National University of 









































Figure 2: Percentage of 12–17-year-olds reporting use of cannabis in the past 30 days, 2018
Source: HBSC Ireland, 2018
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RESPONSES
Dublin NEIC  
progress report
In December 2020, the fourth progress report 
of the North East Inner City’s (NEIC) Programme 
Implementation Board (PIB) was launched by 
Minister for Finance Paschal Donohoe TD.1 NEIC’s 
vision is of making the north east inner city a 
safe, attractive, and vibrant living and working 
environment for the community and its families 
with opportunities for all to lead full lives.
Background
In June 2016, a ministerial taskforce chaired by 
the then Taoiseach Enda Kenny was established 
to support the long-term economic and 
social regeneration of Dublin’s NEIC. A report 
on the area and the challenges it faced was 
subsequently published, which outlined a 
plan for the area’s regeneration, grounded in 
a combination of place-based and people-
based approaches to inform regeneration in the 
NEIC.2 The report led to the establishment of 
the PIB and four subgroups, each of which took 
on responsibility for one of the priority areas 
identified in the report: tackling crime and drugs; 
maximising educational/training opportunities/
creating local employment opportunities; 
creating an integrated system of social services; 
and improving the physical landscape.3 Based 
on a growing understanding of the complex 
challenges facing the NEIC, it was agreed in 
2018 to establish a fifth subgroup to focus on 
substance use and misuse and to enhance the 
services provided.
An evaluation assessment carried out in 2019 
informed the PIB’s decision to move forward 
using what was termed ‘a more structured 
delivery approach to the programme’ (p. 3).4 Its 
aim was to support the programme and focus 
on long-term sustainable outcomes; ensure 
alignment of objectives across the subgroups; 
enhance cross-team collaboration; and ensure 
accountability for the delivery of priority 
actions (p. 3). To deliver on this, a three-year 
strategic plan for 2020–2022 was developed and 
implemented.
2020 progress report and substance use
The 2020 progress report outlines the wide 
range of projects and programmes delivered 
in the NEIC over the year. Activities are linked 
to the six priority workstreams as outlined 
in the strategic plan 2020–2022: enhanced 
policing; maximising educational, training, and 
employment opportunities; family wellbeing; 
enhancing community wellbeing and the physical 
environment; substance use, misuse, and 
inclusion health; and alignment of services.
The subgroup on substance use, misuse, and 
inclusion health focuses on improving health 
outcomes for people who use and misuse drugs 
and alcohol and on promoting inclusion health 
for socially excluded groups experiencing severe 
health inequalities. Its activities in 2020 included:
• Funding three drug and alcohol services 
delivered by voluntary providers. These were 
a drug and alcohol addiction response team, 
a homeless case management team, and a 
residential stabilisation programme. Given 
the ‘significant benefits for local inhabitants’ 
(p. 27)1 of these services, the Department of 
Health made a commitment to provide them 
with mainstream funding for 2021.
• Funding the establishment of a community 
addiction assessment hub for people who use 
non-opioid drugs.
• Providing match funding with Healthy Ireland 
for a community health project to tackle 
health inequalities. Activities will include 
building community knowledge and skills 
around stress management, healthy food, 
smoking cessation, and health literacy.
• Supporting community initiatives, such as 
recovery coaches, dual diagnosis awareness 
and train-the-trainer workshops, and facilities 
for outdoor groupwork during Covid-19.
Among the priorities identified for the group in 
2021 are to monitor and evaluate the inclusion 
health hub; to support the delivery of a health 










   













The PIB progress report for 2020 illustrates the 
wide range of challenges facing those living in 
the NEIC, reflected in the profile of projects 
and programmes funded by the Government’s 
2020 allocation of €6.5 million. In launching 
the report, the Minister of Finance reiterated 
the commitment made in the Programme for 
Government to ‘expand the Dublin North-East 
Inner City model to other comparative areas 
experiencing disadvantage’ (p. 85).5
Lucy Dillon
1 Dublin City Council North East Inner City 
Programme Office (2020) Dublin North East Inner 
City progress report 2020. Dublin: NEIC Programme 
Office. https://www.drugsandalcohol.ie/33577/
Dublin NEIC progress report   
continued
2 Mulvey K (2017) ‘Creating a brighter future’: 
an outline plan for the social and economic 
regeneration of Dublin’s North East Inner City. 
Dublin: Government Publications.  
http://www.drugsandalcohol.ie/26859/
3 Dillon L (2017) Regenerating Dublin’s North East 
Inner City. Drugnet Ireland, 61: 5–7. 
https://www.drugsandalcohol.ie/27214/
4 Dublin City Council North East Inner City 
Programme Office (2019) The social and economic 
regeneration of Dublin’s North East Inner City 
(NEIC): 2020–2022 strategic plan. Dublin: NEIC 
Programme Office.  
https://www.drugsandalcohol.ie/33752/
5 Fianna Fáil, Fine Gael and the Green Party (2020) 
Programme for Government: our shared future. 
Dublin: Department of the Taoiseach.  
https://www.drugsandalcohol.ie/32212/
Brass Munkie winter 
2020 issue published
UISCE, the Union for Improved Services, 
Communication and Education for People 
Who Use Drugs, published the 37th issue of 
Brass Munkie in winter 2020.1 UISCE has been 
publishing the newsletter since 1992, with 
content written by service users and service 
providers. It includes news, interviews with 
service providers and users, information 
about services, advice about harm reduction 
interventions, opinion pieces, and other outputs, 
such as poems, relevant to the experiences of 
people who use drugs (PWUD). Brass Munkie 
covers a wide range of topics and the latest issue 
is no exception. Just some of the content of 
issue 37 is outlined in this article.
Work of UISCE
Central to UISCE’s mission is working with 
service users to advocate for their needs. As 
an organisation it recognises the importance of Brass Munkie issue 37, winter 2020
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representatives from the PWUD community to 
be part of policymaking and working groups that 
affect them. To support this and other elements 
of their work, UISCE is further developing its 
peer support work and looking for peer-led 
outreach volunteers for whom they will provide 
training. UISCE’s role as an advocate is also 
illustrated through the experience of one of their 
service users who needed support in making a 
complaint to their service provider.
Recovery Academy Ireland 
Despite the barriers presented by the Covid-19 
pandemic, seven people with lived experience 
completed their training with Recovery Academy 
Ireland as peer-to-peer recovery coaches in 
September 2020, having started the process 
in October 2019. Training included five days 
as a group and a placement in an addiction 
service, during which they completed 300 
hours of recovery coaching. Interviews with two 
recovery coaches who completed the training 
show the benefits for both those who accessed 
their support and themselves as trainees. They 
describe a process through which they learned 
more about the value of peer-to-peer support 
and having a shared lived experience, gained 
confidence in their abilities, as well as having 
improved their chances of gaining employment: 
‘education will open employment doors for me’ 
(p. 12).
National Family Support Network
The National Family Support Network (NFSN) 
works to support families who are impacted by a 
loved one’s substance use. Covid-19 presented 
challenges to the delivery of its work, which 
tends to be face-to-face with individual families 
or groups. Rather than closing their services, 
those involved nationally continue to provide 
support online or over the telephone. Among the 
additional challenges facing the families due to 
the pandemic were:
• An increase in the number of families being 
impacted by drug-related intimidation, often 
for smaller amounts of debt
• Increased alcohol use in the family
• Increased occurrence of domestic violence.
Overdose awareness and naloxone 
training in Covid
A priority for UISCE is its work on overdose 
response and naloxone training. During 
2020, it continued to train staff and peers on 
how to respond to an opioid overdose and 
administer naloxone, as well as distributing kits 
to people at risk of overdose. UISCE adapted 
its materials, training, and practices to take 
account of Covid-19. This work was carried 
out in collaboration with other stakeholders, 
including staff from Merchants Quay Ireland and 
the Health Service Executive’s (HSE) Naloxone 
Implementation Project.
Other inputs
Other services contributing to this issue included 
Care After Prison; Donore Community Drug 
and Alcohol Team; Drug Related Intimidation 
Initiative; Sex Workers Alliance Ireland; North 
East Inner City Initiative; and the HSE. Among 
contributions from service users was an opinion 
piece by Rick Shaw entitled ‘Unintended 
consequences and good intentions’, which 
focuses the need for more investment by 
Government to address the root causes of 
poverty and addiction. While he expresses 
gratitude to those who work hard to provide 
services, the author considers current provision 
to be just ‘a band aid over an amputation, utterly 
inadequate for the issue at hand’ (p. 36).
As a publication, Brass Munkie highlights the 
complex challenges faced by service users, 
PWUD more broadly, and service providers. 
This issue illustrates how these challenges have 
been accentuated by the Covid-19 pandemic. 
However, it also demonstrates the ingenuity and 
commitment of all involved in their efforts to 
keep services running and to continue to meet 
the needs of PWUD.
Lucy Dillon
1 UISCE (2020) Brass Munkie, 37, Winter. Dublin: 
Union for Improved Services, Communication 
and Education for People Who Use Drugs (UISCE). 
https://www.drugsandalcohol.ie/33680/
Brass Munkie winter 2020  









   














PREVALENCE AND CURRENT SITUATION
Harm reduction in the time of Covid-19: case 
study of homelessness and drug use in Dublin, 
Ireland
OʼCarroll A, Duffin T and Collins J (2020) 
International Journal of Drug Policy, 87: 102966.
https://www.drugsandalcohol.ie/33306/ 
Dublin appears to have performed very well 
as compared to various scenarios for Covid-19 
mortality amongst homeless and drug using 
populations. The experience, if borne out by 
further research, provides important lessons 
for policy discussions on the pandemic, as well 
as broader lessons about pragmatic responses 
to these key client groups irrespective of 
Covid-19. The overarching lesson seems that 
when government policy is well coordinated 
and underpinned by a science-driven and 
fundamentally pragmatic approach, morbidity 
and mortality can be reduced. Within this, the 
importance of strategic clarity and delivery, 
housing, lowered thresholds to methadone 
provision, benzodiazepine (BZD) provision and 
naloxone availability were key determinants of 
policy success. Further, this paper argues that 
the rapid collapse in policy barriers to these 
interventions that Covid-19 produced should be 
secured and protected while further research is 
conducted.
National Drugs Library
Trends in adolescent drinking across 39 high-
income countries: exploring the timing and 
magnitude of decline
Vashishtha R, Pennay A, Dietze P, Marzan MB, Room 
R and Livingston M (2020) European Journal of 
Public Health, 31(2): 424–431. 
https://www.drugsandalcohol.ie/33435/
Evidence suggests adolescent alcohol consumption 
has declined since the turn of the millennium 
in almost all high-income countries. However, 
differences in the timing and magnitude of the 
decline have not been explored across countries.
Previous analyses of the decline in adolescent 
drinking have emphasized the wide reach of the 
changes and their near-coincidence in time. Our 
analysis points to the other side of the picture that 
there were limits to the wide reach, and that there 
was considerable variation in timing. These findings 
suggest that as well as broader explanations that 
stretch across countries, efforts to explain recent 
trends in adolescent drinking should also consider 
factors specific to countries and regions.
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Motivations to decrease and cease substance use in 
third-level students: a scoping review
Whelan E, Dockray S, Dick S, Davoren MP, Heavin C, 
Linehan C and Byrne M (2020) PsyArXiv. 
https://www.drugsandalcohol.ie/33446/ 
The aim of this scoping review was to determine 
factors that relate to student motivations to reduce 
or stop their illicit use of substances, and to increase 
understanding of the factors that may be pertinent in 
behaviour change interventions for substance use in 
this population.
Few efforts have been made to identify motivations of 
third-level students to decrease or cease substance 
use. Promising avenues for future research on 
motivations to change in relation to substance use 
include the social contextual factors, perceptions of 
effects on social relationships, and actions of friends 
and family members to prompt contemplations of 
change.
Experiences of frontline workers’ engagement 
with mental health services for homeless adults in 
Ireland
Devine G and Bergin M (2020) European Journal of 
Homelessness, 14(2): 193–211. 
https://www.drugsandalcohol.ie/33400/  
Ireland is experiencing a deepening homeless crisis 
with few sustainable solutions identified. This study 
explores front-line service providers’ experiences in 
their engagement with mental health services for adult 
service users who are homeless within the South-East 
Region of Ireland. Strauss and Corbin’s Grounded 
Theory approach was used to guide twenty in-depth 
interviews with front line service providers. 
Five key service gaps emerged: (1) inter-agency 
communication and collaboration; (2) assertive 
community recovery-orientated care; (3) training, 
information sharing and up-skilling; (4) building 
and sustaining trust, and (5) discharge planning and 
resource constraints. The findings suggest that 
the provision of bespoke tailored Mental Health 
Services, improved inter-agency collaboration 
and the development of relevant staff educational 
programmes are required. Further research to 
inform targeted service provision, policy and practice 
development is recommended.
Recent publications   continued Is there a recent epidemic of womenʼs 
drinking? A critical review of national studies
Keyes KM, Jager J, Mal-Sarkar T, et al. (2019) 
Alcoholism, Clinical and Experimental Research, 
43(7): 1344-1359.  
https://www.drugsandalcohol.ie/33359/  
We review studies using US national data that 
examined time trends in alcohol consumption 
and alcohol-related harm since 2008. 
Findings suggest that recent trends in 
gender differences in alcohol outcomes are 
heterogeneous by developmental stage. Among 
adolescents and young adults, both males 
and females are rapidly decreasing alcohol 
consumption, binge and high-intensity drinking, 
and alcohol-related outcomes, with gender 
rates converging because males are decreasing 
consumption faster than females. This pattern 
does not hold among adults, however. In middle 
adulthood, consumption, binge drinking, and 
alcohol-related harms are increasing, driven 
largely by increases among women in their 30s 
and 40s. The trend of increases in consumption 
that are faster for women than for men appears 
to continue into older adult years (60 and 
older) across several studies. We conclude by 
addressing remaining gaps in the literature and 
offering directions for future research.
Women negotiating power and control as they 
‘journey’ through homelessness: a feminist 
poststructuralist perspective
Mayock P and Sheridan S (2020) European 
Journal of Homelessness, 14(2): 17–47. 
https://www.drugsandalcohol.ie/33402/ 
Using a feminist poststructuralist framework, this 
paper examines homeless women’s trajectories 
through and out of homelessness based on data 
from a qualitative longitudinal study of women’s 
homelessness in Ireland. 
The analysis uncovers women’s agency, mobilised 
through acts of ‘resistance’ and ‘conformity’, as 
they navigated a landscape where assumptions 
about ‘deserving’ and ‘undeserving’ women 










   













Tackling substance misuse from a problem-
solving justice approach
OʼHare G and Luney P (2020) Irish Probation 
Journal, 17: 43-62. 
https://www.drugsandalcohol.ie/33454/ 
Organisations within the criminal justice system 
have been involved in a number of projects to 
tackle substance misuse, including the Substance 
Misuse Court (SMC) initiative. This initiative has 
its origins in ’problem-solving justice’, which is an 
approach that seeks to tackle the root causes of 
offending behaviour. While the SMC is still in its 
infancy and evolving, early results are encouraging, 
with a sustained participant engagement in 
supervision and treatment rate of 87.5% recorded. 
This paper sets out the findings of an evaluation of 
the SMC conducted in 2019, and looks at the next 
steps in the development of this innovative project.
Access to cannabidiol without a prescription: a 
cross-country comparison and analysis
McGregor IS, Cairns EA, Abelev S, Cohen R, 
Henderson M, Couch D, et al. (2020) International 
Journal of Drug Policy, 85: 102935. 
https://www.drugsandalcohol.ie/33370/ 
In this study, we compared the availability of 
CBD [cannabidiol] products and the associated 
legislative and regulatory background in nine 
selected countries.
There are a variety of approaches in how countries 
manage access to CBD products. Many countries 
appear to permit OTC [over-the-counter] and 
online availability of CBD products but often 
without legislative clarity. As consumer demand 
for CBD escalates, improved legislation, guidelines 
and quality control of CBD products would seem 
prudent together with clinical trials exploring 
the therapeutic benefits of lower-dose CBD 
formulations.
Recent publications   continued Paracetamol-related intentional drug overdose 
among young people: a national registry study of 
characteristics, incidence and trends, 2007-2018
Daly C, Griffin E, McMahon E, Corcoran P, Webb 
RT, Ashcroft DM and Arensman E (2020) Social 
Psychiatry and Psychiatric Epidemiology,  
56: 773–781. 
https://www.drugsandalcohol.ie/33297/ 
This study aimed to describe the characteristics, 
incidence, and temporal trends in paracetamol-
related IDO [intentional drug overdose] among 
young people.
The increase in paracetamol-related IDO among 
specific groups of young people, particularly 
young females is an issue of growing concern. 
Interventions targeting IDO among young people 
are needed, incorporating measures to address the 
availability of paracetamol and aftercare following 
IDO.
Staff awareness of suicide and self-harm risk in 
healthcare settings: a mixed-methods systematic 
review
Dillon CB, Saab MM, Meehan E, Goodwin J, Murphy 
M, Heffernan S, et al. (2020) Journal of Affective 
Disorders, 276: 898-906. 
https://www.drugsandalcohol.ie/33301/ 
This mixed-method systematic review aimed to 
appraise and synthesise evidence from studies 
that explored and promoted healthcare staffʼs 
knowledge and awareness of suicide and self-harm 
risk in healthcare settings.
Long-term, routine face-to-face group training 
programmes should be established to educate 
healthcare staff about suicide risk across all 
professions and in specific patient groups.
55
Issue 77  |  Spring 2021     drugnet Ireland      
Student mental health and well-being: overview 
and future directions
Hill M, Farrelly N, Clarke C and Cannon M (2020) 
Irish Journal of Psychological Medicine, Early 
online, 1-8. 
https://www.drugsandalcohol.ie/33451/ 
This paper, by members of the Youth and 
Student Special Interest Group of the College of 
Psychiatrists of Ireland, contextualises student 
mental health currently and describes future 
directions for this emerging field. It is a call to 
action to develop a structure that supports the 
needs of students with mental health problems 
across the full range of the spectrum from mild to 
severe.
Not really a smoker? A study on the prevalence 
of and attitudes to occasional social smoking in a 
third level institution in Ireland
Murray SA, Lyne SJ, Cryan MD, Mullin M, McGrath D 
and Hayes CB (2020) Irish Journal of Psychological 
Medicine, Early online. 
https://www.drugsandalcohol.ie/33449/ 
This study aimed (1) to determine prevalence 
of occasional/social smoking among third level 
students in an Irish university; (2) to evaluate 
students’ attitudes to occasional/social smoking, 
including perceived benefits and harm; (3) to 
explore when students commenced occasional/
social smoking, their reasons and continued 
smoking habits; and (4) to determine any influence 
of other factors, e.g. alcohol consumption, on 
occasional/social smoking.
Prevalence of self-reported occasional smoking 
among university students was higher than daily 
smoking. Most occasional smokers primarily 
smoked in social contexts. All current smokers 
reported that alcohol increased cigarette intake. 
Effective intervention campaigns tailored to 
determinants of occasional/social smoking are 
needed as part of induction to third level.
Recent publications   continued Pathways to ‘recovery’ and social reintegration: 
the experiences of long-term clients of 
methadone maintenance treatment in an Irish 
drug treatment setting
Mayock P and Butler S (2021) International Journal 
of Drug Policy, 90: 103092. 
https://www.drugsandalcohol.ie/33604/ 
This paper examines the experiences of long-term 
clients of methadone maintenance treatment 
(MMT) in one area of Dublin in the context of a 
recent emphasis on rehabilitation and recovery in 
Irish drug policy.
The findings highlight a disconnect between 
policies that ostensibly aim to promote social 
reintegration and recovery and the experiences of 
individuals who are long-term clients of MMT. Irish 
policy aspirations of facilitating opiate-dependent 
clients to progress along a pathway to recovery 
are difficult, if not impossible, to realise given 
the marginal status of addiction services within 
the health system and the difficulties involved in 










   












Intelligence quotient decline following frequent 
or dependent cannabis use in youth: a systematic 
review and meta-analysis of longitudinal studies
Power E, Sabherwal S, Healy C, OʼNeill A, Cotter D 
and Cannon M (2021) Psychological Medicine,  
51(2), 194–200. 
https://www.drugsandalcohol.ie/33710/ 
This study is a systematic review and meta-analysis. 
We preregistered our review with PROSPERO (ID 
no. CRD42019125624). We found seven cohort 
studies including 808 cases and 5308 controls. 
We found a significant effect for the association 
between frequent or dependent cannabis use in 
youth and IQ change, Cohenʼs d=-0.132 (95% CI 
-0.198 to -0.066) p<0.001. Statistical heterogeneity 
between studies was also low at I2=0.2%. Study 
quality was moderate to high. This translates to 
an average decline of approximately 2 IQ points 
following exposure to cannabis in youth. Future 
studies should have longer periods of follow up to 
assess the magnitude of developmental impact.
Risk perception, changing social context, and 
norms prevent transition to regular injection 
among people who smoke heroin
Harris J, Shorter GW, Davidson G and Best P (2020) 
Drug and Alcohol Dependence, 208: 107878. 
https://www.drugsandalcohol.ie/33688/ 
This qualitative study aims to improve 
understanding of environmental influences 
preventing people who smoke heroin from 
transitioning to regular injection.
Findings illuminate environmental influences 
surrounding and shaping drug consumption 
practices. Harm reduction strategies should 
develop and implement safer smoking rooms, 
community and peer interventions, and improve 
accessibility to opioid substitution therapy and 
low threshold outreach services to prevent 
transitioning to regular heroin injecting.
Recent publications   continued A qualitative study of physical activity and dietary 
practices of people accessing opioid agonist 
treatment in Ireland
Matthews E, Van Hout MC, Scheibein F and 
Cowman M (2021) Heroin Addiction and Related 
Clinical Problems, Early online. 
https://www.drugsandalcohol.ie/33648/ 
This research aimed to explore service user 
experiences of change with respect to physical 
activity and dietary practices since entering 
opioid agonist treatment (OAT). This research also 
explored barriers and facilitators to positive lifestyle 
behaviours among those accessing OAT.
Lifestyle behaviours appear to be positively 
modified during OAT allied to additional health care 
supports in place for service users and a potential 
for improved health and social function. A number 
of barriers, particularly psychological, remain with 
respect to behaviour change for this population. 
This research explores these, with learnings for 
services to support behaviour change.
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An audit of the cervical screening programme in 
the National Drug Treatment Centre (NDTC)
Haran M, Kelly JR, Kennedy L, Hennigan K, Farid 
H, Herteu C, et al. (2021) Irish Journal of Medical 
Science, Early online. 
https://www.drugsandalcohol.ie/33641/ 
This study aimed to audit adherence to the 
National Drug Treatment Centre (NDTC) 
Cervical Screening guidelines before and after 
the implementation of an awareness-raising 
educational intervention.
This completed audit cycle shows that an 
awareness-raising educational intervention can 
significantly improve adherence to a cervical 
screening programme in women with substance 
use disorders (SUDs).
A peer-led survey of student alcohol behaviours 
and motives in undergraduate students
McAleer A, Daly A, Leary S, Barry J, Mullin M and 
Ivers J-H (2021) Irish Journal of Medical Science, 
Early online. 
https://www.drugsandalcohol.ie/33644/
This study examines Irish undergraduate studentsʼ 
behaviours and motives regarding alcohol 
consumption. The study explores both levels and 
patterns of consumption.
Given the high rates of hazardous drinking, the 
development of an alcohol intervention may  
be justified; given the high response rates to  
peer-screening, a peer-led intervention for 
alcohol-related harms may yield positive results.
Recent publications   continued ʼA slippery slopeʼ: a scoping review of the self-
injection of unlicensed oils and fillers as body 
enhancement
Brennan R, Overbye M, Van Hout MC and McVeigh 
J (2021) Performance Enhancement & Health, 8(4): 
100185. 
https://www.drugsandalcohol.ie/33622/ 
This scoping review gathers what is currently 
known on the self injection of body fillers for 
aesthetic purposes, using Arksey and O’Malley’s 
(2005) five stage iterative process scoping review 
methodology. 
It was found that the majority of people who inject 
body fillers are male and do so to grossly increase 
muscle size. Injection of oils and other materials in 
the male genitalia was also described, in addition 
to female self-injection in the breast, hand and 
leg areas for augmentation. A range of health 
consequences were reviewed. Recommendations 
are made for further research into this unique 
phenomenon, which, although relatively rare, 
warrants future research attention considering 
the documented increase in DIY facial fillers and 









   












Factors associated with early and later dropout 
from methadone maintenance treatment in 
specialist addiction clinics: a six-year cohort 
study using proportional hazards frailty models 
for recurrent treatment episodes
Durand L, Boland F, OʼDriscoll D, Bennett K, 
Barry J, Keenan E, et al. (2020) Drug and Alcohol 
Dependence, 219: 108466. 
https://www.drugsandalcohol.ie/33611/
This study aims to identify determinants of time 
to dropout of methadone maintenance treatment 
(MMT) across multiple treatment episodes in 
specialist addiction services in Ireland.
Clients with a previous history of treatment 
dropout and those on low dose methadone should 
be identified as high risk for both early and later 
dropout. Inversely, adherence to treatment, not 
missing methadone doses, is protective.
The suburban-city divide: an evaluation 
of emergency department mental health 
presentations across two centres
McLoughlin C, McLoughlin A, Jain S, Abdalla A, 
Cooney J and MacHale S (2021) Irish Journal of 
Medical Science, Early online. 
https://www.drugsandalcohol.ie/33594/ 
This study aimed to evaluate the characteristics 
of mental health presentations to the emergency 
department (ED) in two different hospital settings.
A large proportion of ED referrals to psychiatry 
constitute patients with unmet social and 
addiction needs, who are seen out of hours. 
This prompts consideration of expanding both 
ED and community services to comprise a more 
multidisciplinary-resourced, 24/7 care model.
Recent publications   continued Risk factors for completed suicide among people 
who use drugs: a scoping review protocol
Murphy L, Lyons S, OʼSullivan M and Lynn E (2020) 
HRB Open Research, 3(45). 
https://www.drugsandalcohol.ie/33653/ 
This paper presents a protocol for a scoping review 
that aims to systematically map and synthesise the 
extent and nature of published, unpublished and 
grey literature related to risk factors for suicide 
among people who use drugs (PWUD).
Collating and thematically categorising the various 
risk factors for suicide among this high-risk 
group will hold important implications for future 
research, policy and practice. The research will 
be disseminated through publication in a peer-
reviewed academic journal and a conference 
presentation, and by sharing the findings with 
key stakeholders working within research, policy-
making and professional practice contexts.
Psychiatry traineesʼ attitudes, knowledge, and 
training in addiction psychiatry: a European 
survey
Orsolini L, Rojnić Palavra I, Duccio Papanti G, 
Potočan M, Quattrone D, Martens M, et al. (2021) 
Frontiers in Psychiatry, 11: 1315. 
https://www.drugsandalcohol.ie/33618/ 
Although psychoactive substance use disorders 
(PSUDs) are a domain of mental health, addiction 
psychiatry is only formally recognized as a 
subspecialty in a few European countries, and 
there is no standardized training curriculum.
Despite a growing spread of PSUDs in European 
countries, addiction psychiatry is a relatively poorly 
trained field within psychiatry training programs. 
Further research should investigate reasons 
for poor training and timings of the educational 
activities to optimize experiential education training 
in addiction psychiatry.
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Prevalence of illicit tobacco use and tobacco tax 
avoidance in pregnancy
McDonnell BP, McCausland R, Keogan S, Clancy 
L and Regan C (2021) Irish Journal of Medical 
Science, Early online. 
https://www.drugsandalcohol.ie/33642/ 
The purpose of this study was to explore the 
purchasing habits of pregnant smokers with regard 
to tobacco expenditure and use of illicit tobacco.
Use of illicit tobacco is low and only a minority 
of women engaged in tobacco tax avoidance. As 
the average price of tobacco in Ireland increases, 
weekly expenditure on tobacco products is a 
significant financial impact on low-income women. 
Smoking cessation would deliver significant 
financial gains in addition to health benefits.
POLICY
The Public Health (Alcohol) Act: spatial issues 
and glaring gaps
Houghton F and McInerney D (2020) Irish 
Geography, 53(2): 179-184 
https://www.drugsandalcohol.ie/33628/ 
The negative impact of alcohol on Irish society 
necessitates that the current opportunity to curtail 
this problem is not missed, as has happened in the 
past. Tackling youth and problematic alcohol use 
and misuse requires a robust response. The current 
Public Health (Alcohol) Act is a valuable start but 
contains a number of serious deficiencies that 
must be remedied. Past examples of equivocation 
by Government on this issue are unacceptable. 
Deficits in this legislation must be addressed 
through amendments as forthcoming sections are 
brought into force.
Recent publications   continued RESPONSES
Head shops and new psychoactive substances: a 
public health perspective
Smyth BP (2021) Irish Journal of Psychological 
Medicine, Early online. 
https://www.drugsandalcohol.ie/33687/ 
In 2010, Ireland found itself at the eye of an 
international storm as a network of head shops 
emerged selling new psychoactive substances 
(NPS) and Irish youth rapidly became the heaviest 
users of NPS in Europe. Within months, the Irish 
government enacted novel legislation, which has 
since been copied by other countries, which 
effectively stopped the head shops selling NPS. 
Critics of this policy argued that it could cause 
harms to escalate. A number of separate studies 
indicate that a range of drug-related harms 
increased amongst Irish youth during the period 
of head shop expansion. Within months of their 
closure, health harms began to decline. NPS-
related addiction treatment episodes reduced 
and admissions to both psychiatric and general 
hospitals related to any drug problem began to 
fall. Population use underwent sustained decline. 
Consequently, the closure of head shops can be 
viewed as a success in terms of public health.
Establishment of a national surveillance system 
to monitor community HIV testing, Ireland, 2018
Brady M, Shanley A, Hurley C, OʼDonnell K, 
OʼTuathail M, Fitzgerald M, et al. (2020) Irish Journal 
of Medical Science, 189(4): 1507-1514. 
https://www.drugsandalcohol.ie/33304/ 
Our aim was to pilot and then introduce sustained 
monitoring of VCBT [voluntary community-based 
HIV testing] in Ireland, through collaboration 
between statutory and non-statutory organisations.
Sustained national monitoring in community 
settings will help inform HIV testing guidelines and 
will enable assessment of the impact of local and 
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Factors explaining variation in recommended 
care pathways following hospital-presenting 
self-harm: a multilevel national registry study
Griffin E, Gunnell D and Corcoran P (2020) BJPsych 
Open, 6(6): e145. 
https://www.drugsandalcohol.ie/33453/ 
The aim of this study was to identify the specific 
hospital and individual factors associated with care 
pathways following hospital-presenting self-harm.
Characteristics of the presenting hospital 
and hospital admission rates influence the 
recommended care pathways following self-harm. 
Provision of onsite mental health facilities and 
specialist mental health staff has a strong impact 
on psychiatric care of these patients.
Physical illnesses associated with childhood 
homelessness: a literature review
Strashun S, DʼSa S, Foley D, Hannon J, Murphy A-M 
and OʼGorman CS (2020) Irish Journal of Medical 
Science, 189(4): 1331-1336. 
https://www.drugsandalcohol.ie/33299/ 
Our aim was to identify and categorize the physical 
morbidities prevalent in homeless children.
This literature review summarized the physical 
illnesses prevalent among homeless children and 
the contributing factors leading to them. Gaps in 
the literature were also identified and included 
a dearth of studies focusing on younger children 
compared with adolescents. Further research 
into prevention and intervention programs for this 
vulnerable population is urgently needed.
Recent publications   continued
